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Abstract
The effect of long term domiciliary oxygen therapy on
the position and shape of the oxygen dissociation curve,
together with other haematologic variables such as 2,3-
diphosphoglycerate (2,3-DPG), haemoglobin concentration,
packed cell volume, mean corpuscular haemoglobin concentration,
and arterial blood gas and pH values, has been studied in
patients with chronic bronchitis. Twenty-six patients were
randomly allocated to receive either no oxygen therapy or
15 hours per day oxygen therapy. The two groups were initially
well matched for age and disablement.
Haemoglobin concentration and packed cell volume (P.C.V.)
were the only variables to differ significantly between the two
groups of patients after start of oxygen treatment, but those
patients receiving oxygen therapy showed significant decreases
in 2,3-DPG, together with haemoglobin concentration and P.C.V.
from the pre-treatment values.
The effect of elevated COHb levels, (similar to those
encountered in patients who smoke) on exercise tolerance was
studied in patients with chronic bronchitis, whose exercise
capacity was already limited due to hypoxaemia. Exercise
tolerance, assessed by the distance walked in 12 minutes, was
lower after elevation of COHb levels, and a significant
correlation was established between calculated femoral venous
oxygen tensions (assuming A(A-V)02 values of 7 and 10 ml/100 ml
blood) and the 12-minute walking distance. (r=0.34, P^O.Ol
and r=0.33, P«^0.01)
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The influence of cigarette smoking on the genesis of
secondary polycythaemia in patients with chronic bronchitis
was also investigated. Those patients who smoked had an
increased erythropoietic response to hypoxaemia. A negative
relationship was demonstrated between arterial oxygen saturation
and red cell mass, if the prevailing carboxyhaemoglobin (COHb)
level in each patient was taken into account when determining
arterial oxygen saturation (r=-0.56, P<0.005). A significant
negative correlation was also established between the calculated
venous oxygen tension of the renal medulla and red cell mass
(r=-0 . 51, P<0.001).
The magnitude of the Christiansen, Douglas, Haldane (CDH)
effect was determined in normal men and women, and also
before and after COHb elevation in patients with chronic
bronchitis. It was found to be similar in all groups and was
not affected by changes in COHb levels. Using the CDH effect
determined in these patients, the contribution of this effect
towards the rise in PC02 seen in hypercapnic bronchitic
subjects when given oxygen was determined, and the importance
of this effect is discussed.
The magnitude of the CDH effect remained constant through
the menstrual cycle in normal women, but in women taking a
combined oestrogen/progesterone oral contraceptive (ethiny-
loestradiol 30;ug, D-norgestrel 0.15 mg) , the CDH effect at
menstruation was significantly lower (P-=0.001) than that
in normal women, but there was no difference at mid cycle.




The quest for knowledge about science, and in particular
respiration, dates back to ancient times. Empeaocles in the
fifth century B.C. was the first to formulate a theory of the
ebbing and flowing of blood to and from the heart, but he
believed respiration took place through the entire skin.
The great Hippocratic era gave many classic descriptions
of thoracic disease, as well as the theory that the heart is
the seat of innate heat, and the purpose of respiration is to
cool this fiery process. However, the views of one man,
Galen (130 - 199 A.D.), dominated the study of respiration for
a longer span than those of anyone else, and although some of
these views were totally unsupported by experiment, they were
believed and taught until the 17th century.
In the early 17th century Harvey described the observations
leading to his theory of the circulation of blood, but this
momentous discovery threw no positive light on the physiology
of breathing, and it was still generally believed that the main
function of respiration was to cool the blood.
Further progress in physiology required corresponding
progress in chemistry, a requirement met before the end of the
17th century by Boyle, Hook, Lower and Mayow. Boyle and Hook
demonstrated that animals and fire would not survive in a
vacuum and Mayow demonstrated a decrease in the volume of air
accompanying respiration and combustion, suggesting a similarity
between the two processes. Lower was the first to notice the
colour change occurring when venous blood becomes arterial as
a result of fresh air in the lungs.
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Following the work of these chemists, the understanding
of respiration lapsed for over a century, mainly due to the
erroneous phlogiston theory of Georg Ernst Stahl, and the next
important step in the understanding of respiration came in the
middle of the 18th century when Joseph Black discovered 'fixed
air' or carbon dioxide was liberated from carbonates by acid,
and was also given off by the lungs. Although this discovery
should have heralded the end of the phlogiston theory, it was
too deeply established to be removed at the first attempt, and,
in fact, when Priestly discovered oxygen shortly after this, he
interpreted his findings as supporting the phlogiston theory.
Because of this, many historians feel that oxygen was merely
isolated by Priestly, and that Lavoisier really discovered it,
by showing that in combustion, oxygen combined with carbon to
form carbon dioxide, whilst hydrogen combined with oxygen to form




Iron was known to be a constituent of blood as early as
1747, when Menghini separated it from the ash of blood by a
magnet, and the presence of iron was proved chemically in 1825
by Endelhardt. Hoppe-Seyler showed in 1864 that haemoglobin
combines loosely with oxygen, but it was not until 1938 that
Haurowitz discovered the reversible change of structure which
accompanies the combination of haemoglobin with oxygen.
Much work was carried out around this time on a wide
range of proteins, including haemoglobin, and almost complete
knowledge was gained as to the number and nature of the amino
acid residues present in the molecule. However, it was not until
the 1950's, following the work of Sanger on the structure of
insulin, vvhich prompted similar studies on other proteins, that
the exact chemical sequence of haemoglobin was discovered.
It was Perutz and co-workers who, in 1960, published work
describing the architecture of the haemoglobin molecule in outline.
This early study, using horse oxyhaemoglobin, revealed nothing
of the inter-relationship within the amino acid sequence, but
did show the four separate globin chains which are identical in
pairs, the members of one pair known as alpha chains and those
of the other as beta chains. As haemoglobin was known to be
similar to myoglobin, the structure of which was known (Kendrew
and coworkers, 1960), Perutz was able to interpret the results
of his work further than would have been possible on the basis
of the results alone, and inferred that there were in each chain
a large proportion of alpha-helices. Seven segments of
alpha-helices were found in the alpha chains (denoted A,B,C,E,F,G,H),
and eight in the beta chains (denoted A,B,C,D,E,F,G,H). The
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haem groups were seen to lie in separate pockets on the surface
of the molecule (Fig. 1). Each haem group contains a porphyrin ring
and a ferrous ion which can form fivefold or sixfold co-ordination
complexes. Four of the co-ordinated groups are the nitrogen atoms
of the porphyrin rings and the fifth is an imidazole group of the
proximal histidine residue in the globin chain. When present,
the sixth co-ordinate is oxygen and, because the surrounds of the
haem groups are strongly hydrophobic, oxygen can combine without
oxidising the ferrous ion to the ferric form (Perutz, 1964). The
detailed sequences of the alpha and beta chains of normal human
haemoglobin were determined by Braunitzer and co-workers and
Konigsberg and co-workers in 1961. The alpha chains are made up of
141 amino acid residues each, and the beta chains of 146 residues each.
Having established the structure of oxyhaemoglobin, Perutz
and his co-workers turned their attention to the structure of
deoxyhaemoglobin. In 1967 Muirhead, Cox, Mazzarella and Perutz
compared electron density maps of oxy- and deoxyhaemoglobin at
a relatively low resolution and were unable to find any
significant differences in the folding or tertiary structure
of the molecules, but the results showed differences in the
quaternary structures, i.e. the positions of the subunits. It
was shown that the two beta chains are displaced in the oxy-
haemoglobin molecule, which reduces the entrance to the central
cavity of the molecule. Also, there is movement of the alpha
chains relative to each other. Although this finding had great
implications for the understanding of the function of haemoglobin,
it was not until higher resolution techniques were used by
Perutz, Muirhead, Cox and Goaman in 1968 and Bolton and Perutz
Figure 1
The chain configuration of the <=* and ft subunits of haemoglob
showing the position of the haem groups in each subunit.
(Perutz, Rossmann, Cullis, Muirhead, Will and North, 1960).
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in 1970 that the important differences between the tertiary
structures were found. From this higher resolution work,
numerous hydrogen bonds were found between the alpha 1 - beta 1
and alpha 2 - beta 2 subunits, which were so strong that in the
transition between the oxy- and deoxy- structures they moved as
rigid bodies. On the other hand, the contact alpha 1 - beta 2
in the oxy-structure was found to be quite different from that in
the deoxy-structure. Salt bridges between the last amino acid
residues of each subunit, which were present in the deoxyhaemo-
globin molecule, were absent in the oxy-structure. These
findings, together with the movement of the iron atom out of
the plane of the porphyrin ring in the deoxy-molecule, provided
the basis for a model to describe the co-operative effect of
the binding of oxygen to haemoglobin, that is, the way in which
the binding of one oxygen molecule facilitates the binding of
the next one. This co-operative effect was first observed
by Bohr in 1903 and accounts for the sigmoid shape of the oxygen
dissociation curve.
A general model of co-operativity had already been applied
to describe facilitated binding of ligand to a protein provoked
by the preceeding binding of the same ligand, by Monod, Wyman
and Changeux in 1965. They postulated that if there are only
two structural conformations of a protein, the one with fewer
bonds would be able to develop greater activity, whereas with
stronger bonds between the subunits, the activity would be
reduced. They termed the structure with fewer bonds R for relaxed
and the other structure T for tense. This theory simplified
the interpretation of co-operative effects enormously, but it
was Perutz who, in 1970, proposed a model to describe co-operativity,
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or haem-haem interaction within the haemoglobin molecule,
based on the existence of two alternative quaternary-
structures (Perutz, 1970).
In Perutz' theory the deoxyhaemoglobin molecule represents
the T state and the oxyhaemoglobin molecule the R state of the
Monod, Wyman, Changeux model. Previous work carried out by
Hoard (196 8) had shown that in the deoxy-conformation, or T state,
the ferrous ion is in a high spin state with a wide diameter,
and thus protrudes out of the plane of the porphyrin ring, but
in the oxy-conformation or R state, it is small enough to fit
into the porphyrin ring. Perutz proposed that as oxygen binds,
the distance between the iron ion and the porphyrin ring
decreases sequentially, and the ion carries the proximal histidine
and the F helix of the globin chain with it, causing a pocket
in the molecule between helices F and H to narrow, expelling a
tyrosine side chain. This movement, in turn, ruptures a salt
bridge between the two subunits, liberating Bohr protons. As
each salt bridge is broken, more constraints holding the molecule
in the deoxy conformation are removed, and the equilibrium
between the two conformations is tipped towards the oxy-conformation,
increasing the affinity of haemoglobin for subsequent oxygen
molecules.
Much of this theory was conjecture, and the structural
connection between the movements of the iron ions and those
of the carboxy termini could not be described. Later, results
of Anderson (1973 and 1975) suggested that such gross movements
did not occur.
o
Maps are now available at resolutions of 2.5 A for
o
human deoxyhaemoglobin and 2.0 A for horse methaemoglobin,
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and more detailed comparisons of the two structures have
been achieved (Fermi, 1975; Ladner, Heidner and Perutz, 1977).
These more recent results show many qualitative similarities
to earlier results, but differ in quantitative aspects, which
provide a more accurate picture of certain important changes
in the molecule, and cast doubts on Perutz' theory that the cause
of the low affinity of the deoxyhaemoglobin conformation was
the energy required to break the salt bridges.
An alternative theory was proposed by Baldwin and Chothia
(1979). As the iron binds oxygen, its position of lowest energy
is in the plane of the porphyrin ring, but steric repulsions
between the iron and the F helix prevent movement of the iron
into the ring. Because the molecule is closely packed, the F
helix cannot move to relax the strain, and decreases the stability
of the quaternary structure so that the proportion of
molecules in the oxy-conformation increases as successive oxygen
molecules bind. The change in the quaternary structure induces
tertiary structure changes that reposition the F helix relative
to the haem group removing the steric repulsion, and
facilitating the binding of oxygen.
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Transport of oxygen by the blood
It was known in 1669 that venous blood turns red when
exposed to air, but further knowledge of the transport functions
of the blood was not forthcoming until the early 19th century
when Gustav Magnus established that arterial blood contained
more oxygen than venous blood, but less carbonic acid.
Hoppe-Seyler, one of the pioneering workers on haemoglobin in
the 19th century, attributed the oxygen combining properties
of blood to haemoglobin, and a chemical combination was suggested
by Claude Bernard's results in 1858 which showed that carbon
monoxide displaced oxygen from the blood.
Paul Bert was the first to investigate the oxygen
dissociation curve in 1872 by plotting the oxygen content of
blood against the barometric pressure of air, but no further
work on the dissociation curve was carried out until 1886, when
Christian Bohr plotted the oxygen dissociation curve of
purified haemoglobin, which resembled a hyperbola as there
ft
were no values below 30% oxygen saturation. Next, Hufner,
who had studied haemoglobin for many years, showed that the
dissociation curve could be fitted by a rectangular hyperbola,
as he had assumed that the reaction of haemoglobin with oxygen
was unimolecular. However, in 1903, Bohr disproved this
assumption by plotting the whole oxygen dissociation curve,
and showing it to have a sigmoid form.
Many workers have investigated the oxygen dissociation
curve, both mathematically and experimentally, since Bohr revealed
the sigmoid shape. In 1910 A.V. Hill attempted a mathematical
analysis of the curve. He assumed that haemoglobin molecules
g
in solution aggregate in the presence of salts, with 'n' molecules
of haemoglobin in the aggregate, while in distilled water,
haemoglobin would be monomeric. The theory is formulated in
the Hill equation:-
y = k (pO^)11 / [1 - (pC^)11] where k and n are constants
y = fractional saturation
of haemoglobin with
oxygen
The slope of the "Hill plot", obtained by plotting log (y/1 - y)
against log pC^, can be used as an indicator of the degree
of co-operativity or haem-haem interaction. If there is no
haem-haem interaction the slope or 'n' is unity. The 'n' value
of oxygen binding to haemoglobin under physiological conditions
is almost constant over a saturation range of 20 - 80% and has
a value of 2.6 - 2.8.
Barcroft tested the validity of Hill's equation by
comparing oxygen dissociation curves calculated using the formula,
with those determined experimentally, and found very good
agreement, both for human blood and that of sheep, dog and cat.
Thus, for many years studies on oxygen and haemoglobin
combination were based on the dissociation curve of blood as
presented by Barcroft in 1914.
However, in 1924, Bock, Field and Adair were unable
to construct oxygen dissociation curves which verified
Barcroft's curves, and although they found Hill's formula was
not adequate to describe the whole curve, it was sufficiently
accurate over most of the physiological range, and it is still
widely used as it provides an informative and convenient way
of representing the oxygen dissociation curve.
In 1925 Adair formulated his general intermediate
compound hypothesis. He proposed that the oxyhaemoglobin
reaction takes place in four steps, each one having its own
microscopic equilibrium constant. As application of this
theory requires accurate measurement at the top and bottom
of the curve, it was not until 1972 that data was fitted
successfully to the Adair equation (Houghton, DeLand, Kernohan
and Severinghaus).
Since 1925 several attempts have been made by various
workers to reduce the number of Adair constants, notably the
theories of Pauling (1935), Monod, Wyman and Changeux (1965) and
Koshland (1966), but Roughton rejected these models on the
basis of very accurate measurements of the dissociation curve.
The oxygen dissociation curve has been investigated
experimentally in great detail by many workers, and a range of
results regarding the position and shape of the curve in human
subjects has emerged. However, in contrast to the variable
position of the curve in health and disease, its shape is
widely believed to be constant between oxygen saturations of
20 - 80% at low carboxyhaemoglobin levels. It has, therefore,
been accepted that the P50, which is the oxygen tension required
to produce 50% saturation of haemoglobin with oxygen (pH 7.4,
PC02 40 mm Hg, temperature 37°C), is sufficient to characterise
the position of the curve.
In 1966, Severinghaus standardised the oxygen dissociation
curve by collecting results from many sources and constructing
an average curve. The P50 of this curve is 26.6 mm Hg at pH 7.4,
PC02 40 mm Hg and base excess 0, with a value for Hill's 'n'
of 2.6.
An increase in P50 indicates a decrease in haemoglobin
oxygen affinity, and a decrease in P50, an increase in haemoglobin
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oxygen affinity, and once the shape of the oxygen dissociation
curve had been established, many workers turned their attention
to investigating the factors which alter the P50 and control
the oxygen affinity of haemoglobin.
(i) Effect of carbon dioxide
In 1904 an important discovery was made by Bohr,
Hasselbalch and Krogh, namely that CC>2, when added to blood,
expels oxygen, a phenomenon which became known as the Bohr effect.
Although Bohr suggested that the converse effect may exist,
i.e. that oxygen would drive out CC>2 from the blood, they
could not demonstrate this at the time, and, in fact, wrote
"no certain action of oxygen pressure on the simultaneous
absorption of CC>2 was observed; if any such action exists, it
is at any rate small and can have no special significance for
the conditions in the living body".
In 1910 Barcroft proved that the expulsion of oxygen
from the blood was not a property of carbonic acid alone. He
found that lactic acid caused a rightward shift in the
dissociation curve and pointed out the usefulness of this
mechanism, as during oxygen shortage, lactic acid is produced
which, by reducing the affinity of haemoglobin for oxygen, will
facilitate oxygen release to the tissues. The Bohr effect
has thus come to mean the effect of changing pH on the oxygen
dissociation curve, as opposed to the effect of changing CC>2
concentration, and is expressed as Alog P02/ApH.
Ten years after the discovery by Bohr, Christiansen,
Douglas and Haldane demonstrated the reciprocal effect, i.e.
that oxygenation of blood caused a decrease in total C02 content,
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a phenomenon which they proposed may be due to oxyhaemoglobin
being a stronger acid than reduced haemoglobin and thereby
driving C02 out of solution. Henderson explained this by
proposing that the combination of haemoglobin with oxygen
increases the dissociation of a single monovalent acid group
in haemoglobin and this would lead to the release of protons
on oxygenation (Henderson, 1920).
This proposal could not be tested experimentally at this
time as it required accurate determination of pH and this
was not possible before 1937. However, with the development
of the glass electrode, German and Wyman were able to measure
titration curves of oxy-and deoxy-haemoglobin with greater
accuracy. They found that oxyhaemoglobin was indeed a
stronger acid than reduced haemoglobin over the pH range
6.1 - 8.9, but the reverse is true between 6.1-4.5. At a
pH of 7.0 they found that the change in the charge on the
haemoglobin molecule as it becomes oxygenated is -0.5 m equivalent
H+ per m equivalent haemoglobin, the experiment being performed
on haemoglobin solution in the absence of COg. This
oxygen-linked hydrogen ion binding, first suggested by the
work of Christiansen, Douglas and Haldane has become known
as the Haldane effect and is expressed as (A Hb-bound H+) /
(A Hb02 from 1 - 100%).
In 1948 Wyman, using the linked function principle,
showed that the Haldane coefficient and the Bohr coefficient
should be equal and this theory was given credence when Dill,
Graybiel, Hurtado, Taquini, in 1940, produced a value of -0.48
for the Bohr coefficient which compared favourably with the
value of -0.50 for the Haldane coefficient given by German
and Wyman (1937).
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However, when investigating the Bohr effect, the pH
of the blood can be altered by two methods: the addition of
C02 or the addition of fixed acid or base. The difference
between these two methods only became significant when,
in 1955, Margaria and Milla compared the effect of respiratory
(i.e. C02-induced) pH changes and metabolic (i.e. fixed acid
induced) pH changes on the oxygen dissociation curve. They
found that at any given pH, a pure solution of horse haemoglobin,
in the absence of C02, has a greater oxygen affinity than a
haemoglobin solution in the presence of CC>2, confirming earlier
work of Margaria and Green (1933). They attributed this
effect to the formation of C02~haemoglobin complex in the form
of a carbamate, which has a lower affinity for oxygen than
simple haemoglobin, and whose formation has been shown to be
2
proportional to pH (Ferguson and Roughton, 1934 J.
This additional effect of CC>2 on the dissociation curve
was later confirmed in human whole blood by Naeraa, Strange
Petersen and Boye (1963), who, on the basis of their results,
proposed that the Bohr factor would alter depending on whether
the pH was changed by C02 or fixed acid. However, much
controversy arose when Colman and Longmuir (1963) and Astrup,
Engel, Severinghaus and Munson (1965) produced results which
suggested there was no pH-independent effect of CC>2, but the
issue was settled in 1966 when Naeraa, Strange Petersen,
Boye and Severinghaus found the C02 Bohr effect approximates
Alog P02 = -0.5 ApH, whereas the fixed acid Bohr effect, measured
at constant PC02, approximates Alog P02 = -0.4 ApH, the
difference being due to the formation of carbamate, which accounts
for 20% of the C02 Bohr effect.
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In 1969, Bauer investigated the fixed acid Bohr effect
in the presence and absence of CC>2, using purified haemoglobin
solutions. He found the fixed acid Bohr effect, in the absence
of C02, was similar to the C02 Bohr effect, but in the
presence of C02, the fixed acid Bohr effect was reduced. This
was confirmed by Dahms, Horvath, Luzzana, Rossi-Bernardi,
Roughton and Stella (1972) and also byArturson, Garby, Robert
and Zaar (1974) who used whole blood, and is due to the pH-dependent
formation of carbamates when C02 is present, for at low pH there
is little carbamate formation, but as the pH rises, carbamate
formation increases and although the increased pH acts to
lower the P50, the increased carbamate counters this, with
the result that Alog P50/ApH is lower than in the absence of
C02, where no carbamates form on raising pH, and thus no antagonism
of the Bohr effect is seen.
The effect of C02 on the Haldane coefficient was first
demonstrated by Rossi-Bernardi and Roughton (1967). They found
that the Haldane effect in the absence of C02 was constant over
the pH range 6.8 - 7.6. However, when PCC>2 = 39 mm Hg, the
Haldane effect was halved at pH 7.2, and decreased further as
the pH increased. In fact, at PC02 50 mm Hg and pH 7.5, the
Haldane effect was reversed and haemoglobin solutions became
more alkaline on oxygenation. They explained this as being
due to the buffering effect of carbamate. As carbamino-bound
C02 dissociates from haemoglobin on oxygenation, it removes H+
ions from solution, thereby reducing the change in H+ ions
caused by oxygenation. As carbamate formation increases at high
pH and PC02 values, a point is reached where as many protons are
removed by dissociation of carbamate as are added by oxygenation,
15
and beyond this point the Haldane effect will be reversed.
This reduction of the Haldane effect by CC>2 has been confirmed
in haemoglobin solutions by Kilmartin and Rossi-Bernardi (1969)
and Siggaard-Anderson (1971) and in whole blood by Siggaard—
Anderson and Sailing (1971).' However, Mithoefer, Thibeault and
Bossman (1969) were unable to show the reversal of the Hal¬
dane effect in dog whole blood despite the use of higher
and pH values than Rossi-Bernardi and Roughton (1967).
According to Wyman (1948) the Bohr effect is determined
exclusively by the interaction between oxygen and hydrogen ions,
and not influenced by other ligands of haemoglobin. However,
it is now known that the Bohr and Haldane effects vary, not
only with C02 concentration, but also with 2,3-diphosphoglycerate
(2,3-DPG) concentration and oxygen saturation.
The effect of 2,3-DPG on the fixed acid Bohr effect in
haemoglobin solutions was first investigated by Bauer (1969),
who found little effect of 2,3-DPG in the absence of C02, but
at PCO2 levels of 40 mm Hg, 2,3-DPG caused an increase in the
Bohr effect. As 2,3-DPG influenced the Bohr effect only in the
presence of COg, Bauer proposed that it acts by reducing carbamate
formation at increased pH, and in 1970 was able to prove this.
Subsequent work on whole blood confirmed the effect of 2,3-DPG
on the fixed acid Bohr effect (Wranne, Woodson, Detter, 1972;
Hlastala and Woodson, 1975; Duhm, 1976), but the C02 Bohr effect
was reduced in the presence of 2,3-DPG (Wranne, Woodson and
Detter, 1972). This again is due to suppression of carbamate
formation by 2,3-DPG. As carbamate formation at high pH is minimal
under these conditions due to the necessarily low PC02, it is
not affected significantly by 2,3-DPG, but as the pH is lowered by an
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increased PC02, 2,3-DPG depresses carbamate formation, thereby
reducing the rightward shift of the oxygen dissociation curve and
hence the C02 Bohr effect. Investigation of these complex
inter-reactions led Hlastala and Woodson (1975) to the
conclusion that at normal levels of 2,3-DPG, the C02 Bohr effect
is primarily a direct effect of H+ ions, but on 2,3-DPG depletion,
carbamate formation plays a much more important role.
The Haldane effect was also found to be enhanced by 2,3-DPG
(Siggaard-Anderson, 1971), a result which bears out the proposal
of Arnone (1972), that the binding of 2,3-DPG is accompanied by an
increase in the pK value of the positive groups in haemoglobin.
This enhancement of the Haldane effect by 2,3-DPG may explain why
Mithoefer et al (1969) were unable to demonstrate the reversal
of the Haldane effect by C02 when using fresh whole blood, and in
fact, Bauer (1970) suggested that if 2,3-DPG had been present
in the haemoglobin solutions used by Rossi-Bernardi and Roughton
(1967), the Haldane effect would not have been reversed.
Until the mid-1960's it was generally believed that the
Bohr effect was independent of oxygen saturation (Antonini, Wyman,
Brunori, Bacci, Fronticelli and Rossi-Fanelli, 1963), i.e. the
Bohr effect at 50% oxygen saturation was indicative of that at
all other saturations, but in 1967 Kernohan and Forster showed that
at high oxygen saturations, the Bohr effect was lower than at
mid saturation values.
In 1972, Garby, Robert and Zaar investigated the C02 and
fixed acid Bohr effects over the whole oxygen saturation range,
and found they did indeed change with oxygen saturation. The
fixed acid Bohr effect was maximum at mid saturation values and
fell off as saturations approached 0 and 100%, whereas the C02
Bohr effect was maximum at low oxygen saturation values and became
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lower as saturation increased, reflecting the reduction of
carbamate formation as the oxygen saturation rises.
The binding sites of the oxygen-linked hydrogen ions
have now been mapped as a result of an extensive study involving
x-ray crystallography and chemical modification of the
haemoglobin molecule. From the work of Benesch and Benesch(1961)
and Perutz (1970) it appears that the C-terminal histidines of
the 3^chains of haemoglobin account for 50% of the Bohr protons
released on oxygenation, and Kilmartin and Rossi-Bernard in 1969
showed that the amino group of the N-terminal valine of the two
oc-chains accounts for a further 25% of the Bohr effect. Perutz
in 1970 also suggested that the imino group of one of the histidine
residues of the ^-chains may contribute to the Bohr protons.
According to a theory by Perutz, all the above groups participate
in formation of salt bridges in the deoxyhaemoglobin molecule,
which causes the pK value for the dissociation of protons to be
raised. In oxyhaemoglobin, the salt bridges rupture, the pK values
fall and protons are released. As the pH becomes more acid, the
weak bases in the haemoglobin molecule (with pK values at about
neutrality) will be charged and able to form salt bridges,
thereby increasing the stability of the deoxy form relative
to the oxy form and lowering the oxygen affinity. As the pH
becomes more alkaline, the weak bases will be uncharged, so that
salt bridges will not be formed, thus decreasing the stability
of the deoxy form and increasing the oxygen affinity.
The additional effect of CO2 on oxygen affinity is also
believed to be due to salt bridge formation between the negatively
charged carbamino group and a positively charged group in the deoxy¬
haemoglobin molecules, probably the £-amino group of lysine 82 in
the 6-chain. This salt bridge stabilizes the deoxy conformation
thereby lowering oxygen affinity.
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ii) 2,3-Diphosphoglycerate
Almost 60 years ago Adair, Barcroft and Bock (1921) demon¬
strated that oxygen dissociation curves determined using
haemoglobin solutions differed markedly from curves determined
using blood dialysed against distilled water, which contained
intact, though swollen, red blood cells. This led the authors to
speculate that there may be a third substance, other than
hydrogen ions and salts, which was present in the red cells,
and formed an "integral part of the oxygen-haemoglobin complex",
and hence altered the oxygen dissociation curve. This speculation
received support from the work of Hill and Wolvekamp in 1936,
which showed that the dialysable material from laked erythrocytes
decreased the oxygen affinity of haemoglobin, but they did not
link this effect to the presence of 2,3-diphosphoglycerate
(2,3-DPG), which had been reported to be present in high
concentrations in porcine red blood cells by Greenwald in 1925.
Rapoport and Guest (1941) reported high concentrations of organic
phosphates in most other mammalian species, with exceptions such
as ungulates. They found 2,3-DPG was the most abundant of the
organic phosphates in the red cell, with a molar concentration
in human erythrocytes nearly equal to that of haemoglobin, at about
5 mM.
Although it seems appropriate that the red cell derives
some advantage from this high concentration of 2,3-DPG, which
is four times greater than the concentration of ATP, no important
function was attributed to it until over 40 years after
its discovery.
In 1965 Chanutin and Curnish found a slow moving
electrophoretic band appeared after phosphate compounds were
added to purified haemoglobin solutions, proving that 2,3-DPG
can form complexes with haemoglobin, at least in solutions of
low ionic strength. However, the break-through in 2,3-DPG
research did not come until 1967 when Benesch and Benesch and
also Chanutin and Curnish, in the same year, discovered that
2,3-DPG could alter the oxyhaemoglobin dissociation curve in
a dramatic way. Using dialysed human haemoglobin solutions,
Benesch and Benesch found haemoglobin-oxygen affinity was very
high and there was little haem-haem interaction. On addition of
2,3-DPG in physiological concentrations, the haem-haem inter¬
action increased and oxygen affinity decreased to normal values.
They found further addition of 2,3-DPG had little effect on the
curve and concluded that P50 and Hill's 'n' reached their maximum
values at the concentration of 2,3-DPG found in the red cell.
This displacement of oxygen by 2,3-DPG strongly suggested
that deoxyhaemoglobin had a greater affinity for 2,3-DPG than
oxyhaemoglobin and in 1968 Benesch, Benesch and Yu showed that
DPG bound only to deoxyhaemoglobin in dilute haemoglobin
solutions. They claimed the reduction in oxygen affinity by
2,3-DPG could be accounted for solely by this preferential binding
to deoxyhaemoglobin, which stabilises the deoxy-conformation.
However, in 1977, Goodford, Norrington, Paterson and Wootton
showed that 2,3-DPG not only stabilises the deoxy-conformation of
haemoglobin relative to the oxy-conformation, but it also lowers
the oxygen affinity of the deoxy-conformation, producing a
two conformational, three affinity state system.
In 1969, Garby, Gerber and de Verdier investigated the
binding of 2,3-DPG to haemoglobin under conditions similar to
those prevailing in the erythrocyte, and found that 2,3-DPG was,
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in fact, bound by both deoxyhaemoglobin and oxyhaemoglobin, the
affinity for 2,3-DPG of the former being, under physiological
conditions, about twice that of the latter, a result confirmed
by Chanutin (1969) and Caldwell, Nagel and Jaffe (1971).
Benesch et al (1968) investigated the effect of a wide
range of 2,3-DPG concentrations on the oxygen dissociation curve
of dilute haemoglobin solutions, and from their results concluded
that variations of organic phosphate levels in the physiological
range would have little effect on haemoglobin oxygen affinity.
However, this was disputed in the same year byLenfant, Torrance,
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English, Finch, Reynafarje, Ramos and Faura, and Rorth who
found changes in 2,3-DPG levels corresponded to dramatic changes
in oxygen-haemoglobin affinity in vivo. This anomaly prompted
Duhm (1971) to investigate the differences in the effect of
2,3-DPG on haemoglobin in solution and in intact red cells. In the
red cell he found a remarkable rightward shift in the dissociation
curve when 2,3-DPG levels were increased above normal, and
attributed this to a shift in the Donnan equilibrium induced by
the accumulation of non-penetrating phosphate anions in the
cell which causes a decrease in intracellular pH. This, in turn,
lowers the oxygen affinity, by the Bohr effect, and accounts
for the greater effect of 2,3-DPG on oxygen affinity of intact
red cells. This effect was quantitated by Bellingham, Detter
and Lenfant (1971) who found that a change in 2,3-DPG
concentration of 6.0 ymoles/g haemoglobin alters the difference
between plasma and red cell pH by 0.058 pH units, which accounts
for about 35% of the overall change in P50^7 brought
about by 2,3-DPG. Thus, in the red cell, 2,3-DPG influences
oxygen affinity by two mechanisms: by a specific action on the
haemoglobin molecule and also by an unspecific effect on red cell pH.
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Benesch, Benesch and Yu (1969) found 2,3-DPG binding
to haemoglobin was influenced by various environmental factors.
pH was found to regulate 2,3-DPG binding, an increase in pH
leading to a reduction in the binding of 2,3-DPG, an observation
later confirmed by Garby and de Verdier (1971) and Caldwell,
Nagel and Jaffe (1971). Consequently, the effect of 2,3-DPG on
oxygen affinity is more pronounced at low pH values, and as a
result of this, Benesch et al (1969) found 2,3-DPG enhanced the
Bohr effect.After Siggaard Anderson( 1971 }De Bruin, Janssen and
Van Os (1973) similarly showed 2,3-DPG increased the Haldane
effect, expressed as the number of protons exchanged during
oxygenation of deoxyhaemoglobin. They showed this enhancement
was due to an uptake of protons following an increase in pK of the
positive groups in the haemoglobin molecule, which occurs
upon binding of 2,3-DPG to deoxyhaemoglobin.
OtheS* factors which influence 2,3-DPG binding are:
temperature, the binding constant decreasing as temperature
increases, and anions such as chloride ions, which compete with
2,3-DPG for the oxygen-linked binding site. An apparent
competition between 2,3-DPG and CO^ was suggested by the work
of Bauer (1969, 1970) which showed 2,3-DPG decreased the amount
of carbamino-bound C02 at constant pH and PC02. This was confirmed
by Tomita and Riggs (1971) who found C02 can totally abolish the
effect of 2,3-DPG on oxygen affinity at high pH.
2,3-DPG Binding Sites
The important finding by Benesch et al (1968) of the
simple 1 : 1 stoichiometry of the 2,3-DPG-haemoglobin interaction
suggested that the 2,3-DPG binding site must lie on the dyad axis
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of symmetry passing through the centre of the molecule. Subsequent
work by Benesch, Benesch and Yu (1969) and Garby, Gerber and
de Verdier (1969) showing that 2,3-DPG binding decreased
considerably between pH 7.0 and 8.5, suggested that 2,3-DPG
binds to positively charged groups with pK values in the
physiological range of pH, and could therefore be accommodated
by the <*-amino groups or histidines.
It was shown by Benesch and Benesch (1969) that 2,3-DPG
would bind to isolated g-chains, but not to isolated <*-chains,
suggesting that the binding of 2,3-DPG to normal haemoglobin
occurs only in the g-chains.
Studies on human foetal haemoglobin by De Verdier and Garby
(1969) produced additional information on the 2,3-DPG binding
site. They found 2,3-DPG bound less readily to foetal haemoglobin
in which histidine 143 (H21) on.the non-alpha subunit is replaced by
serine (Schroeder, Shelton, Shelton, Cormick and Jones, 1963)
and this result suggested that the DPG-binding site was on the dyad
axis of symmetry in the internal cavity between the two g-chains
and involved histidine 143g. The «-amino group of valine 1 g (NA 1)
is also present in this cavity and Bunn and Briehl (1970)
demonstrated its involvement with 2,3-DPG binding, since 2,3-DPG
had a considerably diminished effect on the oxygen affinity of
foetal haemoglobin and glycosylated haemoglobin, where the N-terminal
amino groups of the non-alpha chains are bound to an acetyl
group and hexose respectively. The involvement of the o=-amino
groups was confirmed independently by Caldwell, Nagel and Jaffe
(1971) and Tomita and Riggs (1971) who found the formation of
carbamate by C02 at the a-amino groups of haemoglobin reduced the












































The binding position of the 2,3-DPG molecule in the human deoxy-
haemoglobin structure. The negative charges on each phosphate
group are shared between the residues valine 1 and histidines 2
and 143 in the s-subunits. (Arnone, 1972).
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Perutz (1970), using x-ray crystallographic data,
found that if a model of 2,3-DPG was placed on the dyad axis
of symmetry of a model of reduced haemoglobin, the charged
groups on the 2,3-DPG molecule were within hydrogen-bonding
distance of the N-terminal valines, lysine 82 (EF6) and
histidine 143 (H21) of the 8-chains. Furthermore, on
oxygenation, the distance between the <*-amino groups increases,
disrupting the hydrogen-bonds with 2,3-DPG, and the central
cavity narrows, thus expelling 2,3-DPG and accounting for the lower
affinity of 2,3-DPG for oxyhaemoglobin.
In 1972, Arnone succeeded in producing a difference
electron density map between the human deoxyhaemoglobin-DPG
complex and normal deoxyhaemoglobin which confirmed the binding
of 1 mole 2,3-DPG to 1 mole haemoglobin at the entrance to
the central cavity, which involves hydrogen-bonding to seven
cationic groups of the 3-chains: valines 1 (NA1), histidines 2 (NA2)
and 143 (H21), and one of the lysines 82 (EF6) (Fig. 2).
Regulation of 2,3-DPG Concentrations
The pathway for the formation of 2,3-DPG was found by
Rapoport and Luebering in 1950-52, and is now known as the
Rapoport-Luebering shunt (Fig. 3). 2,3-DPG is synthesised from 1,3
diphosphoglycerate by the action of diphosphoglycerate mutase
(DPG-mutase), and is decomposed to 3-phosphoglycerate and inorganic
phosphate by 2,3-diphosphoglycerate phosphatase (DPG-phosphatase).
Both these reactions are irreversible and involve the same
enzyme protein for catalysis. Thus, this cycle bypasses the
phospnoglycerate kinase reaction in the glycolytic pathway and
consequently no ATP is formed. Approximately 20% of the




















The Rapoport-Luebering pathway for the synthesis of 2,3-DPG,
and its position in the main Embden-Meyerhof pathway.
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2,3-DPG was calculated to be 0.3 - 0.75 ymoles per hour per
millilitre of cells (Chiba and Sasaki, 1978).
Various factors control the concentration of 2,3-DPG
under physiological conditions. In 1952, Rapoport and Luebering
reported a negative feedback mechanism whereby 2,3-DPG
inhibits the enzyme DPG-mutase when concentrations rise above
the optimum level.
Hydrogen ion concentration has a considerable influence
on 2,3-DPG concentrations. In alkalosis, the rate of glycolysis
and the activity of DPG-mutase is increased and the activity
of 2,3-DPG phosphatase inhibited, leading to an elevation of
2,3-DPG concentrations. In acidosis these changes are
reversed with a subsequent reduction in 2,3-DPG levels. However,
a change in pH would appear to exert opposing influences on
2,3-DPG levels, as a rise in pH, for example, would increase
DPG-mutase activity and increase 2,3-DPG synthesis, but it
would also lower the amount of 2,3-DPG bound to haemoglobin,
increasing the concentration of free 2,3-DPG, which would, in
turn, inhibit DPG-mutase activity, illustrating the complex
regulatory role of pH.
The ADP/ATP ratio will decide whether 1,3-diphosphoglycerate
enters the Rapoport-Lueberingshunt or proceeds through the
glycolytic pathway. A high ratio facilitates the flux
through the ATP synthesising step in the glycolytic pathway,
whereby less 2,3-DPG will be formed.
Inorganic phosphate concentration can also regulate
2,3-DPG levels, as shown by Lichtman, Miller, Cohen and
Waterhouse (1971), who found decreased levels of 2,3-DPG
in hypophosphataemia, and elevated levels in hyperphosphataemia.
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As the target for the regulation of the pathway must
be the activity of free 2,3-DPG, the metabolism will tend
to preserve a certain level in the free form. Thus, as
reduced haemoglobin binds more 2,3-DPG than oxyhaemoglobin,
it was anticipated by several authors (Benesch et al, 1968;
Lenfant et al, 1968) that the level of 2,3-DPG depends upon
the oxygenation of haemoglobin.
Lenfant et al (1968) found a marked rise in 2,3-DPG
concentrations within 24 hours in subjects taken from sea level
to 4530 m above sea level. This increased concentration was
restored to normal on return to sea level and the authors
related this effect to the reduced oxyhaemoglobin saturations
and not to the alkalinity observed at altitude, for residents
at high altitudes, brought to sea level, showed reduced levels
of 2,3-DPG without any change in acid-base status. Studies
by Oski, Gottlieb, Delivoria-Papadopoulos and Miller (1969)
support this theory, although a direct relationship between
oxygen saturation and 2,3-DPG levels was not observed. However,
in 1970, they were able to show a correlation between 2,3-DPG
levels and arterial oxygen tension, in patients with hypoxaemia
due to congenital heart disease. However, normal 2,3-DPG
levels were observed by Gallagher (1971) in asthmatic patients
with low arterial oxygen tensions. Edwards and Canon (1972)
similarly found normal 2,3-DPG levels in patients with chronic
obstructive lung disease with associated acidosis. Fairweather,
Walker and Flenley (1974), investigating 2,3-DPG levels in
patients with chronic obstructive lung disease found the average
2,3-DPG concentration of the group was normal, although values
both above and below the normal range were encountered, showing
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Figure 4
A schematic summary of mechanisms influencing 2,3-DPG
concentration changes in the red blood cells during hypoxia.
(Duhm and Gerlach, 1971).
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the variability of response of 2,3-DPG to hypoxic stimulus (fig 4).
In 1971, Duhm and Gerlach investigated the effect of
oxyhaemoglobin saturation on the synthesis and breakdown of
2,3-DPG in vitro, and found the rate of decomposition of 2,3-DPG
was independent of oxygen saturation, but synthesis increased
markedly in deoxygenated red cells. They suggested this may
be due to the more alkaline intracellular pH on deoxygenation
which would activate DPG-mutase and inhibit DPG phosphatase.
2,3-DPG levels are also influenced by exercise. Kunski
and Sztobryn (1976) observed lower concentrations immediately
following exercise in trained subjects, and elevated concentrations
following exercise in untrained subjects. Ramsey and Pipoly
(1979) also investigated 2,3-DPG levels after exercise, but
in contrast to Kunski et al, found 2,3-DPG levels fell after
exercise in untrained subjects. They attributed the fall to
increased lactate concentrations causing acute acidosis with
subsequent reduction in 2,3-DPG synthesis.
There is controversy, also, regarding the effect of age
on 2,3-DPG. In 1974, Purcell and Brozovic reported a
progressive decrease of 2,3-DPG concentration with advancing
age, but Tweeddale, Leggett and Flenley (1976) found no
such correlation in 62 subjects ranging in age from 18 - 89 years.
iii) Carbon Monoxide
Humans have always been exposed continuously to small
quantities of carbon monoxide endogenously produced from the
normal catabolism of haemoglobin, with a minor fraction
contributed by the breakdown of non-haemoglobin haem. In
healthy males at rest, the average rate of endogenous carbon
monoxide production is approximately 0.4 ml per hour, resulting
in a carboxyhaemoglobin (COEb) saturation of 0.4 - 0.7%,
which has been considered neither beneficial nor harmful
(Stewart, 1976).
Most exogenous carbon monoxide is produced from the
incomplete oxidation of carbonaceous material, the major source
in the environment being the exhaust of motor vehicles and
the remainder resulting from industry. Tobacco smokers are
the most heavily exposed non-industrial segment of the population,
and some may have COHb levels as high as 20%.
Modern studies on the interaction of carbon monoxide with
haemoglobin can be said to date from the work of Claude Bernard
in 1857, when it was shown that carbon monoxide displaces
oxygen from haemoglobin. Haldane and Lorrain Smith (1897)
investigated the combination of oxygen and carbon monoxide with
ox haemoglobin, and concluded that when haemoglobin was
saturated with oxygen and carbon monoxide, the relative
proportions of oxy-and COHb are proportional to the relative
partial pressures of the two gases, allowing for the fact that
the affinity of carbon monoxide for haemoglobin is approximately
300 times greater than that of oxygen.
However, in 1897, the oxygen dissociation curve was
thought to be a rectangular hyperbola, and the influence of
carbon dioxide and salts on the curve was unknown. This
prompted Douglas, Haldane and Haldane (1912) to reinvestigate the
combination of oxygen and carbon monoxide with haemoglobin, in
the light of subsequent discoveries regarding oxygen-haemoglobin
interactions. They found the conclusions of Haldane and
Lorrain Smith were correct and applicable even in the presence
of various carbon dioxide concentrations. They constructed
equilibrium curves for carbon monoxide and haemoglobin combination
and found them to have the same sigmoidal form as those for
oxygen and haemoglobin combination, and they proposed that
COHb dissociation curves could be made to coincide with the
corresponding oxygen dissociation curves over their whole range,
merely by altering the scale of carbon monoxide partial
pressures. However, Joels and Pugh (1958) studied COHb
dissociation curves using more accurate methods, and although
they found excellent agreement between COHb and oxyhaemoglobin
dissociation curves over the mid saturation range, at high
saturations, the COHb curves lay slightly below the oxyhaemoglobin
curves.
In their classic study, Douglas et al (1912) found that
when COHb is present in blood, oxygen is given off from oxy¬
haemoglobin to the tissues in an abnormal way. This observation
was investigated further by Stadie and Martin (1925) and
Roughton and Darling (1944) who studied the effect of a wide
range of COHb levels on the oxygen dissociation curve. As a
result of this work, it has been generally accepted that
partial saturation of haemoglobin with carbon monoxide not
only decreases the amount of oxygen which haemoglobin can carry,
but also shifts the oxygen dissociation curve of the remaining
haemoglobin progressively to the left, indicating an increase
in the affinity of haemoglobin for oxygen, and alters the slope
of the curve, making it less S-shaped. Okada, Tyuma, Ueda and
Sugimoto (1976) found that Hill's 'n' (a measure of the haem-haem
interaction obtained from the slope of the Hill plot) gradually
decreases as COHb levels are raised, falling from 2.6 at 0%
COHb to 1.4 at 60% COHb.
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These authors suggested that the effect of carbon
monoxide in increasing the oxygen affinity of haemoglobin can
be explained according to the intermediate compound hypothesis
of Adair (1925). The hypothesis states that the combination
of haemoglobin with oxygen or carbon monoxide takes place in
four steps, and the association constant for each step increases
as the ligand is bound, indicating a rise in haemoglobin
oxygen affinity. Therefore, if the combination of haemoglobin
with carbon monoxide takes place in a similar manner to that
with oxygen, and the partially saturated carboxyhaemoglobin is
assumed to be equivalent to the partially oxygenated haemoglobin,
then increased fractions of carboxyhaemoglobin should lead to
a higher oxygen affinity of the remaining haemoglobin.
For these reasons, the hypoxic symptoms produced by
carbon monoxide intoxication are more severe than those
produced by anaemia, despite the same blood oxygen content (Fig- 5 )•
In their study, Roughton and Darling (1944) developed a
theoretical procedure for calculating the position of the oxygen
dissociation curve in the presence of COHb, and this has shown
agreement with experimental results (Okada et al, 1976).
In addition to its effect on the oxygen dissociation curve,
carbon monoxide affects other factors associated with oxygen
transport. In 1956, Eisen and Hammond, investigating the effects
of elevated COHb in smokers, found that haematocrit, red
cell count and haemoglobin concentrations were higher during
periods of cigarette smoking than during abstinence periods,
but the time course of these responses was not clearly elucidated.
Wilks, Tomashefski and Clark (1959) exposed dogs to carbon




Oxyhaemoglobin dissociation curves of normal human blood,
blood containing 50% COHb, and blood containing 50% of the
normal amount of haemoglobin, showing that for any given arterio¬
venous 02 content difference, the subject with 50% COHb will
have a lower venous P02 than the subject with 50% anaemia.
(Bartlett, 1968).
to carbon monoxide was increased. They attributed this to an
increase in the concentration of haemoglobin,which would produce
a greater oxygen capacity at any COHb concentration. Later
investigations on humans, showed an immediate post-carbon
monoxide exposure rise in haemoglobin and haematocrit, which
subsided within 48 hours and could be attributed to a fall
in plasma volume, together with a delayed, more prolonged rise
in haemoglobin and haematocrit related to erythropoietic
activity (Ramsey, 1969).
Cigarette smokers, who are chronically exposed to low
levels of carbon monoxide, have been investigated by several
groups. Sagone, Lawrence and Balcerzak (1973) found significantly
higher haematocrit, haemoglobin, red cell counts and red cell
mass in a group of cigarette smokers, despite normal arterial
oxygen tensions. The erythropoietic response was attributed
to lower arterial oxygen saturations, expressed as a percentage
of total haemoglobin (Sagone and Balcerzak,1975) and this was
confirmed by Smith and Landaw (1978). It is believed that
hypoxia at some site within the kidney releases erythrogenin,
an enzyme able to act on one of the plasma proteins to produce
erythropoietin, which, in turn, stimulates the bone marrow
to increase erythropoiesis (Gordon and Zanjani, 1970).
In view of the leftward shift of the oxygen dissociation
curve induced by carbon monoxide, a subsequent effect of
carbon monoxide on 2,3-DPG concentrations has been sought.
Dinman, Eaton and Brewer (1970) exposed normal human volunteers
and also rats to carbon monoxide at two levels of exposure.
The treated rats showed marked elevation of 2,3-DPG with the
low carbon monoxide exposure, but no change with the high exposure.
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Similarly, 2,3-DPG levels increased in human subjects given
the low dose of carbon monoxide, but there was no change in
subjects given the larger dose. The authors were unable to
account for these results using existing theories of 2,3-DPG
regulation and suggested that hypoxia caused by carbon monoxide
triggers some other mechanism which elevates 2,3-DPG. However,
in the same year, Astrup (1970) investigated the effect of
similar COHb levels over a period of 24 hours, and observed a
fall in 2,3-DPG concentrations, which he attributed to a
change in red cell pH resulting from the decrease in reduced
haemoglobin when COHb levels rise. Other investigators have
found 2,3-DPG is totally unaffected by elevation of COHb in
both acute and chronic exposure studies (Sagone et al, 1973;
Ramsey and Casper, 1976; Thomas and Penney, 1977; Smith et
al, 1978).
Okada et al (1976) reversed the emphasis and investigated
the effect of 2,3-DPG on the shift of the oxygen dissociation
curve produced by COHb and found the shift in the curve
was constant in the presence and absence of 2,3-DPG. They
also found that COHb had no effect on the fixed acid Bohr
effect, a result which was contested by Hlastala, McKenna,
Franada and Detter (1976) who found the fixed acid and C02 Bohr
effects increased as COHb levels rose, but were unable to
explain the difference of results.
As carbon monoxide is so detrimental to oxygen transport,
it is to be expected that exercise capacity will be impaired
by high COHb levels. In 1910, Nicolai and Staehelin determined
upon themselves the effect of smoking, and found an increase
in heart rate and blood pressure after a measured amount of work.
Juurup and Muido (1946) measured work capacity after smoking,
and again found increased heart rates, but COHb levels were not
monitored during these studies.
From more recent studies, a number of investigators have
shown a linear decline in aerobic power, or maximal oxygen
uptake (VOg max), as COHb levels rise (Ekblom and Huot, 1972;
Vogel and Gleser, 1972; Pirnay, Dujardin, Deroanne and Petit,
1971) so that the subject with higher COHb levels is effectively
working at a higher relative work load, and the critical level
of COHb above which maximum aerobic power would be impaired was
found to be as low as 4.3% COHb (Horvath, Raven, Dahms and 1
Gray, 1975).
Oxygen Transport in Chronic Bronchitis
By the 19th century, the clinical diagnosis of emphysema
and chronic bronchitis with chronic ventilatory failure was
well known. Chronic ventilatory failure (Type II respiratory
failure) is defined as being present when the arterial C02
tension is chronically elevated above the normal range, and the
arterial 02 tension is below the normal range. In order to
maintain an adequate supply of oxygen to the tissues, numerous
adaptive mechanisms are employed, and the mechanisms affecting
the relationship between haemoglobin and oxygen are discussed.
There is much uncertainty about changes in the oxygen
affinity of haemoglobin which occur in chronic obstructive
airways disease. Edwards, Novy, Walters and Metcalfe (1968)
and Lyons and Tabak (1972) found increased P50 values (corrected
to pH 7.4 (PSQ^.q)) in all patients with chronic airways
obstruction. However, Lenfent, Ways, Aucutt and Cruz(1969) found
the situation less clear-cut, and that the oxygen affinity
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depended on the haematocrit, being increased in patients with
normal haematocrit values, but reduced in patients with a
haematocrit greater than 50%; the P50 (7.4) increasing with
the degree of polycythaemia. In a more recent study, Denis, Feret,
Nouvet, Pasquis, Stain, Weisang, Morere and Lefrancois (1977)
found increased P50 (7.4) values only in patients with
a comparative anaemia, a result contrary to that of Lenfant
et al (1969).
On the other hand, a number of studies indicate no
consistent alteration of oxygen affinity from the normal value
in patients with chronic obstructive airways disease, despite
severe hypoxaemia (Guy, Kazura, Bromberg and Balcerzak, 1971;
Astrup, 1969; Edwards and Canon, 1972; Fairweather, Walker
and Flenley, 1974). However, in these studies no attempt
was made to compare the P50 values of the patients with those
of similarly aged healthy subjects, and as P50 (7.4) was found
to increase with age (Tweeddale, Leggett and Flenley, 1976),
Tweed dale, Leggett and Flenley (1977) compared oxygen affinity
in patients, with that in age-matched normal subjects. They
found no difference in P50 (7.4) between the two groups,
although the value was higher than that given by the standard
oxygen dissociation curve of Severinghaus (1966).
The Bohr effect in patients with airways obstruction
was found to lie within the normal range (Edwards et al, 1968;
Lenfant et al, 1969), but Edwards et al (1968) found haem-haem
interaction was increased in these patients, although Lenfant
et al (1969) found it to be normal.
Concentrations of 2,3-DPG in these patients have also
been reported as altered, or unchanged. Oski, Gottlieb,
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Delivoria-Papadopoulos and Miller (1969) found 2,3-DPG
concentrations were significantly higher in patients with chronic
bronchitis, but many studies have shown normal 2,3-DPG
concentrations, despite hypoxaemia in these patients (Guy
et al, 1971; Edwards and Canon, 1972; Fairweather et al, 1974;
Tweeddale et al, 1977 and Denis et al, 1977). Respiratory
acidosis may account for the lack of elevation of 2,3-DPG
concentrations in some patients with chronic obstructive airways
disease.
It must be remembered that in patients with respiratory
acidosis, the P50 in vivo will be higher than the corresponding
P50^, ^ due to the Bohr effect. However, this benefit of a
lower oxygen affinity may be curtailed if the low pH acts to
reduce 2,3-DPG levels, but such a fall in 2,3-DPG below normal
levels was not observed in any of these studies, and the rightward
shift of the oxygen dissociation curve in vivo, due to the Bohr
effect was, therefore, not counterbalanced. Edwards et al (1972)
estimatedfrom their results that the mean in vivo P50 value
would be 30 mm Hg in patients with chronic obstructive lung
disease and acidosis.
Although this rightward shift in the oxygen dissociation
curve was held to be an important adaptation in hypoxia,
Flenley, Fairweather, Cooke and Kirby (1975) showed that large
variations in P50 had comparatively little effect on oxygen
transport, assessed by venous oxygen tensions, when hypoxic
patients were breathing air. They explained this paradox as
being due to the shape of the dissociation curve. When the
arterial 02 tension lies below the shoulder of the curve, two
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Figure 6a
Oxyhaemoglobin dissociation curves with P50(7_4) values of
20 mm Hg (left curve) and 30 mm Hg (right curve). With arterial PO2
= 100 mm Hg and an arterio-venous 02 saturation difference of 25%.
there is considerable difference in terms of venous PO2 between
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Figure 6b
Oxyhaemoglobin dissociation curves with P50(7_4) values of 20 mm Hg
(left curve) and 30 mm Hg (right curve). With arterial P02 = 40
mm Hg and an arterio-venous O2 saturation difference of 25%,
the venous points on the curves are close in terms of PO2•
(Flenley, Fairweather, Cooke and Kirby, 1975).
0o tensions for a given arterial-venous 0„ content difference ,(A(A-V)02).2 ^
However, when the arterial 0^ tension lies over the shoulder
of the curve, the venous 02 tensions differ markedly, the patient
with the higher P50 having the advantageous value. Thus, in
patients with low arterial 0^ tensions, the shift in the curve
produced by elevated 2,3-DPG levels will afford little advantage
to tissue oxygenation (Figs.6a and 6b ).
A further adaptive mechanism to maintain tissue oxygenation
is an increase in red cell production. It was originally
believed that hypoxaemia is generally not accompanied by a
rise in haemoglobin concentration (Baldwin, Cournand and Richards,
1949; Wilson, Borden and Ebert, 1951). However, Vanier, Dulfano,
Wu and Desforges (1963) demonstrated that it is, in fact,
accompanied by an increase in red cell mass which, because of
changes in plasma volume, is not always reflected in a rise
in haemoglobin or haematocrit. An inverse relationship was
subsequently demonstrated between arterial oxygen saturation
and red cell mass in patients with chronic airways
obstruction (Weil, Jamieson, Brown and Grover, 1968; Chan, 1969;
Harrison, 1973), but Guy et al (1971) found that only half of the
patients that they studied had an elevated red cell mass, and
suggested that the response is not stereotyped and may be
modified by the underlying disease state.
Oxygen Therapy in Chronic Bronchitis
It has been recognised for many years that administration
of oxygen to selected patients with chronic airways obstruction
was of clinical benefit. Oxygen was first given therapeutically
to patients with tuberculosis by Chaussier in 1780, and although
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the clinical diagnosis of chronic bronchitis and emphysema was
well known in the 19th century, the serious therapeutic use
of oxygen for the treatment of the disease did not come until the
early part of this century. Haldane (1919) suggested that
long term oxygen therapy may benefit patients with chronic
obstructive lung disease, but this was not investigated until
1926, when Campbell andPoulton studied patients residing
for 1-3 weeks in a chamber containing 40% oxygen. Although
the condition of the patients improved, it was not long-lasting,
and no relief of the associated secondary polycythaemia was
observed, as longer-term continuous oxygen therapy was difficult,
due to the cumbersome equipment necessary.
In 1956, Cotes and Gilson described portable oxygen
equipment which could be used in the home. They found from
their study that administration of 30% oxygen was almost as
beneficial to the patients as 50% or 100% oxygen, and would
minimise the toxic effects of oxygen. Long term oxygen therapy for
ambulatory patients became possible in 1967 following the
introduction of lightweight apparatus for carrying liquid
oxygen (Linde walker), and the value of such continuous oxygen
therapy in patients with severe hypoxaemia has been demonstrated
by many research groups. A reduction in haemoglobin concentration,
haematocrit and red cell volume was observed following oxygen
therapy for at least 12 hours per day over periods of time
ranging upwards from six weeks (Chamberlain and Millard, 1963;
Petty and Finigan, 1968; Leggett, Cooke, Clancy, Leitch, Kirby
and Flenley, 1976; Block, Castle and Keitt,1974). Mean
pulmonary artery pressure and pulmonary vascular resistance was
reduced in some patients (Horsfield, Segel and Bishop, 1968;
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Levine, Bigelow, Hamstra, Beckwitt, Mitchell, Nett, Stephen
and Petty, 1967; Leggett et al, 1976), and Block et al (1974)
observed a fall in 2,3-DPG concentration following oxygen
therapy for four weeks.
However, correction of hypoxaemia by oxygen administration
to patients with chronic obstructive bronchitis may lead to
carbon dioxide retention (Donald, 1949; Westlake, Simpson and
Kaye, 1955), a phenomenon attributed to the removal of a ventilatory
stimulus from hypoxia, whereas a rise in C02 tension is a
relatively inefficient stimulus to ventilation in these patients.
The Transport of CO2 by the Blood
The transport of C02 by the blood has been of interest
to physiologists for over a century, and by the beginning
of this century it was known that most of the C02 in the
blood was in loose chemical combination, the plasma holding
about two-thirds, and the red cells about one-third of the
total. Much of this loose chemical combination of C02 was
known to take place via reactions shown:
where A represents phosphates or other such substances.
In 1914, Christiansen, Douglas and Haldane established'
the shape of the CO2 dissociation curve, and having constructed
curves for fully oxygenated and reduced blood, found that
oxygenated blood carried less C02 than reduced blood at any
given PC02 value. They suggested this was because oxyhaemo-
globin was a stronger acid than reduced haemoglobin which
caused equations (1) and (2) above to move to the left. They
were unable to prove this at the time, however, as pH could
not be measured accurately.
C02 + H2O H2CO3 (1)
H2C03 + NaA HA + NaHC03 (2)
On the basis of their results, they proposed that this 02~linked
C02 expulsion would contribute 30 - 40% of the C02 expelled
in the lungs, and, as such, was of great physiological
importance. It was later demonstrated that the shape of the CO,,
dissociation curve and position can vary between individuals
(Liljestrand and Lindhard, 1920; Meakins and Davies, 1922),
and is dependent upon the haemoglobin concentration (Brocklehurst,
Haggard and Henderson, 1927).
The idea of a direct combination of C02 and haemoglobin
was first suggested by Bohr, but no evidence for this compound
was produced until, in 1928,Henriques found that when haemoglobin
solutions were shaken in vacuo, C02 was liberated very rapidly
to begin with, and then at a slower rate similar to that found
when plasma was shaken in vacuo. He proposed the first
rapid phase was due to the dissociation of a carbamate-type
compound of CC>2 and haemoglobin, and the slow phase to the
uncatalysed reaction:
H+ + HC0~ * H20 + C02 (3)
However, by 1932 an enzyme for the above reaction had been
isolated by Meldrum and Roughton, and given the name carbonic
anhydrase.
Further support was given to Henriques suggestion of
a reversible carbamate compound of C02 and haemoglobin by
Margaria and Green in 1933. They showed that the first
ionisation constant of carbonic acid changed when haemoglobin
was added to the solution and suggested this was due to a
combination of some C02 with haemoglobin. However, the matter
was finally settled by Ferguson and Roughton in 1934. They
developed a method for the quantitative estimation of C02 bound
to ox haemoglobin, and produced evidence to show that C02 binds
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as carbamate to -NH2 groups in the haemoglobin molecule. They
then investigated the effect of pK and oxygen saturation on
the formation of carbamates. A rise in pH from 7.8 to 8.6
increased the carbamino-bound CC>2 almost sixfold, a result
which was expected, as Faurholt, in 1925, had carried out
experiments on carbamino compounds of amino acids, and found the
following reactions were involved:
PNH* : » PNH2 + H+ (4)
PNH2 + C02 ; — PNHCOOH (5)
PNHCOOH . ^ PNHCOO" + H+ (6)
Hence a rise in pH would drive equations (4) and (6) to the
right, increasing carbamate formation.
Oxygenation, under otherwise static conditions, caused
a reduction in carbamino-bound C02, which they attributed to
steric hindrance to the combination of C02 caused by the
attachment of the neighbouring oxygen molecule. This oxygen-linked
carbamate formation, together with the increase in pH which
occurs in deoxygenation, accounts for the higher CC>2 content
of deoxyhaemoglobin, first demonstrated by Christiansen, Douglas
and Haldane in 1914 and which has become known as the
Christiansen, Douglas, Haldane (C.D.H.) effect.
In a subsequent paper, Ferguson (1936) applied the same
methods to human haemoglobin and calculated that in man
carbamino-C02 is responsible for about 30% of the total changes
in C02 in the whole blood during the respiratory cycle. In 1937
Stadie and O'Brien confirmed and extended the work of Roughton
and Ferguson. Using horse and ox haemoglobin solutions, they
verified Roughton and Ferguson's calculations as to the role
of carbamates in the circulation and brought forth new evidence
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suggesting that the increased carbamate formation in
deoxyhaemoglobin is dependent on the same -NH9 groups whose
power of combination with H+ ions is greatly altered by
oxygenation and thus responsible for oxyhaemoglobin being
a stronger acid.
However, in 1948, Wyman put the whole matter of
oxygen-linked carbamate formation in some doubt by pointing
out that if the above proposals were correct, the -NH2
groups in deoxyhaemoglobin would be in the charged form, -NH^4",
and therefore unable to combine with C02. Wyman's proposal
was that C02 combined with the Z-NH2 groups which are not
influenced directly by oxygenation, but whose power of carbamate
formation is proportional to pH. He suggested that the
greater carbamate formation of deoxyhaemoglobin is due purely
to the rise in pH accompanying reduction, which he calculated
would be about 0.1 pH units. Using some of Ferguson's data,
Wyman showed that this pH change could account for the difference
in carbamate formation between oxy and deoxyhaemoglobin.
However, Roughton, in 1949, pointed out that if all the
data was used, it would not fit Wyman's hypothesis well.
The dispute rested until 1962, when Rossi
and Roughton measured the pH change accompanying oxygenation
and found it to be only half of Wyman's estimate, and thus
could not account solely for the difference in carbamino-bound
C02 observed by Ferguson in deoxy- and oxyhaemoglobin. Rossi-Bernardi
and Roughton confirmed this result in 1967 and also demonstrated that
reduced haemoglobin solutions contained more CC>2 than oxy¬
haemoglobin solutions at the same pH and PC02 levels, thus
proving beyond doubt that in the physiological range, carbamates
are oxylabile. This differenece in C02 content between oxy and
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reduced haemoglobin was shown to increase as pH rose, an
observation later confirmed in whole blood by Mithoefer, Thibeault
and Bossman (1969). On the basis of these results, they were able
to reconfirm the role of carbamate in the transport of C02 and
calculated that 26.7% of the C02 carried by the circulating
blood is carried as carbamate.
In 1969, Bauer reported that 2,3-DPG reduces the amount
of C02 bound as carbamate in haemoglobin solutions, an
observation subsequently confirmed by Pace, Rossi-Bernardi and
Roughton (1970), who found the C02 content of reduced haemoglobin
with 2,3-DPG present, was half that in 2,3-DPG depleted
solutions. With this knowledge, Rossi-Bernardi and Roughton (1970)
reassessed the role of carbamate in the transport of C02 by
the blood, and calculated that carbamate in the erythrocytes may
only play about half the role previously computed in physiological
C02 transport. Bauer (1970) extended his previous studies
and investigated directly the effect of 2,3-DPG on carbamate
formation. He confirmed the above results and suggested that
in the presence of 2,3-DPG there is a reduction in the binding
sites for C02 rather than a direct competition, as it
appears that 2,3-DPG binds to the amino groups of the 8 chains, only
when they are in the charged -NH2+ form, where no carbamate
could be formed.
TT
In 1972, Bauer and Schroder estimated carbamino-bound
C02 in adult and foetal red blood cells, and although the amount
of carbamate present in oxygenated adult and foetal cells was
the same, they found reduced foetal haemoglobin formed more
carbamate compounds than reduced adult haemoglobin. This
observation was consistent with Bauer's hypothesis, as foetal
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haemoglobin has a lower affinity for 2,3-DPG than adult
haemoglobin (De Verdier and Garby, 1969), and therefore
antagonism to carbamate formation is low. The contribution
of carbamate to physiological CC>2 transport was calculated
and found to account for only 10.5% of the total C02 transported,
a figure similar to that proposed by Rossi-Bernardi and Roughton
(1970) having taken the influence of 2,3-DPG into account.
In 1973, Klocke also showed the antagonistic effect of 2,3-
DPG on carbamate formation, and investigated the total C02 content
change on oxygenation at various pH values, and divided this
change into that due to the change in carbamate and that due
to the change in bicarbonate. He found the total C02 change
on oxygenation was maximum at pH 7.40 and remained constant
up to pH 7.6, but the relative contributions of carbamate
and bicarbonate varied markedly. For a PC02 of 42.5 mm Hg
and a normal 2,3-DPG concentration, the change in carbamate
on oxygenation equalled the change in bicarbonate, at a pH of
7.5. Above this, carbamate contributes most to the total C02
change, and below this pH value, bicarbonate contributes
the greater part, hence at the normal pH of 7.4, 40% of
the total C02 change is due to the change in carbamate
and 60% to the change in bicarbonate (fig.7).
Although initially there was much controversy over
which -NH2 groups were involved in carbamate formation,
in 1967 Rossi-Bernardi and Roughton produced evidence which
supported the idea that it is terminal * amino groups, rather
than E-amino groups that are responsible for carbamate
formation. The identification of the groups responsible was
undertaken subsequently by Kilmartin and Rossi-Bernardi
(1969, 1971) using horse haemoglobin which had been modified
at the oc amino groups with cyanate, to give three derivatives:
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Figure 7
Variation in oxylabile carbamate, bicarbonate and total CO2
content as a function of pH at a mean PCO2 of 42.5 mm Hg.
(Klocke, 1973).
C C G C
a2 ^2 ' ^2 ^2 and<x2^2 ' where superscript c denotes a
specifically reacted a amino group. They determined
carbamino-CO^ indirectly by observing the change in oxygen
affinity at constant pH, which is believed to be due to carbamate
formation. In unmodified haemoglobin a large change in
oxygen affinity was observed in the presence of CC^, but in
c c c
<*2 $2 » ^2 kac* no effect on oxygen affinity, whereas ^ $2 an<*
<X2^2C sllc>wed intermediate effects, confirming that all four
N-terminal amino groups are responsible for carbamate formation.
This work was confirmed and extended by Kilmartin, Fogg,
Luzzana and Rossi-Bernardi in 1973 using human haemoglobin
modified in the same way. They found that C02 had a greater
c c
effect on the oxygen affinity of <*2 22 "tlian on that oc2^2 '
indicating there is a large change in the C02 binding constants
of the 3 subun it amino group between oxy and reduced forms
of haemoglobin. In addition they found the change in oxygen
affinity of *2 3 2 caused by C02 was not diminished by the
presence of 2,3-DPG, but the change in oxygen affinity of
cc2°^2 ^ CO2 was markedly reduced after addition of 2,3-DPG,
showing that 2,3-DPG interferes with the C^-linked binding of
carbon dioxide only at the =amino groups of the 3-subunits.
In 1974, Arnone attempted to locate the binding of
CO2 to crystalline human deoxyhaemoglobin directly using
x-ray studies. His work confirmed that C02 reacts with the
N-terminal amino groups of the 3 chain, but was unable to show
any combination with the <= chain amino groups, which may have
been due to the conditions used in the study. However, in 1975,
Perrella, Kilmartin, Fogg and Rossi-Bernardi, and other workers
(Bauer, Bauman, Engels and Pacyna, and Perrella, Bresciani and
ossi-Bernardi) showed that the 3subunit N-terminal amino groups
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have a threefold higher affinity for C02 than the chain N-terrainal
amino groups when DPG is absent,which may be explained with the
help of results obtained by Matthew, Morrow, Wittebort and
Gurd in 1977. They evaluated pKz, the negative log. of the
ionisation constant for the reaction:
HbNH3+ HbNH2 + H+ (7)
and also pKc, the negative log. of the equilibrium constant
of the reaction:
HbNH2 + C02 ^ HbNHCOO" + H+ (8)
for the N-terminal a amino groups of the <= and g subunits. These
values revealed that the N-terminal = amino groups of the °=
subunits are primarily protonated in deoxyhaemoglobin, and
therefore much less free to form carbamino derivatives than
the N-terminal =* amino groups of the 6 subunits which are primarily
unprotonated at physiological pH. They also found that as
haemoglobin is oxygenated, pKc for the g-chain N-terminal amino
groups is raised, which causes equation (8) to move to the
left, and thereby explains why the N-terminal a amino groups
of the g-chains form and discharge more carbamate than those
groups of ^-chain. In the same year, Bauer and Kurtz (1977)
showed that a tetrameric molecular structure is a
prerequisite for the binding of oxygen-linked carbamate, as
no carbamate formation was detectable in monomers despite
the presence of free terminal aamino groups.
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Summary
Haemoglobin is a tetrameric protein molecule comprising
two a and two 3subunits. Each subunit contains a haem group,
at the centre of which is an iron atom which can combine reversibly
with oxygen or other ligands. The tertiary structures of the
« and 3subunits are similar, consisting of seven helical regions
in the ® subunit, and eight in the 3subunit. The quaternary
structure of haemoglobin varies as ligands bind and dissociate,
this change playing an important part in the functional role of
haemoglobin.
o
Based on comparisons of electron density maps at 2.8 A
resolution, and of atomic models of deoxy and liganded haemoglobin,
structural explanations of haemoglobin function have been proposed.
There are at least two distinct quaternary conformations in
equilibrium with each other which correspond to the liganded
and unliganded state. The former state has fewer bonds between
subunits and thus can develop full oxygen affinity, whereas
unliganded haemoglobin has strong bonds between the subunits
and thus has a lower oxygen affinity.
There is little information about the dynamics of the
structural changes accompanying ligand binding. However, the
most recent theory which attempts to explain these conformational
changes suggests that steric strain, arising as the liganded
ferrous ion attempts to move to its optimum position in the
haemoglobin molecule, decreases the stability of the deoxy
quaternary structure, so that it changes to the liganded
quaternary structure, and induces tertiary structure changes,
which impose no restraints to subsequent ligand binding
(Baldwin and Chothia, 1979).
It is this co-operative binding of oxygen by haemoglobin
which produces the characteristic sigmoid shape of the oxygen
dissociation curve.
If the low affinity deoxy-structure is stabilized, or
destabilized relative to the oxy-structure, the overall oxygen
affinity will be decreased or increased. It has become clear
over the last decade that most changes in the oxygen affinity
of normal haemoglobin can be explained solely by changes in the
stability of the deoxy-conformation, the oxy-conformation
remaining unaltered.
This is true of the Bohr effect, whereby hydrogen ions
increase the stability of the deoxy-conformation relative to
the oxy-conformation. Much work involving x-ray crystallography
as well as chemical modifications, has shown that a number of
groups in the haemoglobin molecule act as weak bases. In the
charged state, these groups, which include the imino group of
the C-terminalhistidine of the B-chains, the amino group of the
N-terminal valine of the ^-chains, and possibly the imino group
of one of the histidines of the ^-chains, participate in the
formation of salt bridges which stabilize the deoxy conformation
As hydrogen ion concentration decreases, the groups lose some
of their charge, reducing salt bridge formation, and decreasing
the stability of the deoxy-conformation, allowing the oxygen
affinity to increase.
Perutz also postulated that it was the breaking of the
salt bridges on oxygenation which causes a reduction in the
pK of these weak bases, with the resultant release of protons,
characteristic of the Haldane effect.
2,3-DPG lowers oxygen affinity by a similar mechanism
of binding to the positively charged groups in the deoxy-
haemoglobin molecule and stabilizing the conformation. Chemical
and crystallographic analysis identified the 2,3-DPG binding
site as the entrance to the central.cavity which involves the
N-terminal «amino groups, histidines (2) and (143) and one of
the lysines (82) of the 8 chains. The binding of 2,3-DPG
to these groups not only stabilizes the deoxy-conformation, but
also decreases the oxygen affinity of the deoxy-conformation,
producing a two conformational, three affinity-state system.
On oxygenation, the sides of the central cavity converge and
the 2,3-DPG molecule is expelled.
The binding of 2,3-DPG to haemoglobin is pH-dependent,
increasing as the pH falls, and it is now known that 2,3-DPG
binds to oxyhaemoglobin as well as deoxyhaemoglobin, although
the affinity of 2,3-DPG for oxyhaemoglobin is only about half
of that for deoxyhaemoglobin.
Carbon dioxide has the ability to alter the oxygen affinity
of haemoglobin, not only by its effect on pH, but also by
reacting reversibly with the N-terminal amino groups of the
« and 8subunits to form carbamate compounds. Although carbamate
formation occurs at all four N-terminal amino groups, those
of the 8subunits have a three-fold higher affinity for carbon
dioxide than those of the ® subunits, as the latter are primarily
protonated in deoxyhaemoglobin, and carbon dioxide will only
react with uncharged groups.
The structural explanation for the effect of carbon
dioxide on the oxygen affinity is believed to be a salt bridge
formed between the negatively charged carbamate group and a
positively charged group in the deoxyhaemoglobin molecule ,
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probably the e-amino group of a g-chain lysine. On oxygenation
these interactions are disrupted and the pK of the carbamate
groups is raised,, causing the carbamate to dissociate, and
explains why deoxyhaemoglobin contains more carbon dioxide
at any given carbon dioxide tension than oxyhaemoglobin.
Carbon monoxide, unlike the other ligands of haemoglobin
mentioned above, combines reversibly with the ferrous ion in the
haem group, with the result that oxygen transport is impaired
by two mechanisms: carbon monoxide lowers the oxygen carrying
capacity of the blood, and increases the oxygen affinity of the
remaining haemoglobin, resulting in impaired release of
oxygen to the tissues.
Since the affinity of haemoglobin for carbon monoxide
is approximately 200-250 times its affinity for oxygen,
exposure to low carbon monoxide concentrations can result in
clinically significant impairment in oxygen transport.
All the ligands mentioned above are involved in complex
interactions which determine the oxygen affinity of haemoglobin (fig 8).
In view of the fact that carbon dioxide and 2,3-DPG combine
with the N-terminal amino groups of the gchains, a competition
between the two ligands is to be expected. As a result of this
competition, the contribution of carbamate to the in vivo
transport of carbon dioxide in the blood is lower than originally
calculated, and only 10.5% of carbon dioxide is carried as
carbamate. Similarly, carbon dioxide at a partial pressure of
40 mm Hg reduces 2,3-DPG binding by 25%. Thus the combined
effect of carbon dioxide and 2,3-DPG on the oxygen affinity will
not simply be the sum of their individual effects.
As the binding of 2,3-DPG and carbon dioxide to haemoglobin




The composite effects of C02, 2,3-DPG, and pH in human erythro-
lysate on the oxygen affinity of haemoglobin. (Rorth, 1972).
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acid Bohr effect is lower in the presence of carbon dioxide
than in its absence, an effect due to carbamino-bound carbon
dioxide exerting its own influence on the oxygen dissociation
curve. Similarly, the Haldane effect is reduced in the presence
of carbon dioxide because on oxygenation the dissociation of
carbamate compounds removes H+ ions and reduces the change in
H+ caused by oxygenation.
At physiological pH, 2,3-DPG increases the fixed acid
Bohr effect, which appears to be caused by suppression of
carbamate formation. However, 2,3-DPG has the opposite effect
on the carbon dioxide Bohr effect, which is reduced in the presence
of 2,3-DPG. This effect is again due to suppression of carbamate
formation, with the result that at normal 2,3-DPG levels, the
COg Bohr effect is primarily a direct effect of H+ ions.
The Haldane effect is increased by 2,3-DPG due to an
increase in the pK values of the weak bases when 2,3-DPG binds
to haemoglobin.
The quantitative contribution of protons, carbon dioxide
and 2,3-DPG towards the oxygen affinity will depend on the pH.
On the acid side of physiological pH, 2,3-DPG and proton binding
will predominate, as 2,3-DPG binds to charged groups and
increases the Bohr effect. On the alkaline side of
physiological pH, carbon dioxide binding will predominate
as it binds mainly to uncharged amino groups and decreases
the Bohr effect, so that changes in proton or 2,3-DPG concentra¬
tion will have a smaller effect on the oxygen affinity.
The situation in vivo is further complicated as the
3oncentration of 2,3-DPG, as well as its binding constant,
/aries with pH. Thus, in acute respiratory acidosis, with a
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rise in PCO^, "the oxygen dissociation curve will be displaced
to the right by the Bohr effect, and to some degree, by greater
carbamate formation at the higher PC02, and also by increased
2,3-DPG binding to haemoglobin. However, after several hours,
2,3-DPG concentration will fall, and the dissociation curve
will be displaced to the left by reduced binding of 2,3-DPG
to haemoglobin, and also by the rise in intracellular pH which
will accompany the reduction in 2,3-DPG concentration. The
in vivo consequence is that the oxygen dissociation curve remains
fairly constant in established respiratory failure, although the
in vitro P50^ will fall.
In metabolic acidosis, where carbon dioxide tension
remains constant, carbamate formation will not increase as in
respiratory acidosis, and may, in fact, fall, with the effect
that the initial rightward shift in the oxygen dissociation
curve would not be as great as in respiratory acidosis.
In respiratory alkalosis the Bohr effect, together with
a decrease in 2,3-DPG binding and carbamate formation will
contribute to the leftward displacement of the oxygen dissociation
curve. However, the subsequent rise in 2,3-DPG concentration,
in response to the alkaline pH, will shift the curve back to
the right with the result that, in vivo, the P50 is normal.
Again, in metabolic alkalosis, at a constant carbon
lioxide tension, the changes outlined above will occur, but
arbamate formation will increase and antagonise the leftward
hift in the oxygen dissociation curve.
In hypoxaemia due to chronic bronchitis, complicated by
ypercapnia, the above mechanisms will operate to maintain an
iequate oxygen supply to the tissues, but further compensatory
3Chanisms may also operate, such as increased red cell production
and 2,3-DPG concentrations, but changes and adaptations
amongst these patients are by no means uniform.
CHAPTER 2
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Aims of the Present Study
The clinical benefit of oxygen administration to
selected patients with chronic obstructive pulmonary disease
has been recognised for many years. Various groups have found
oxygen therapy can control congestive right heart failure and
secondary polycythaemia, and improve exercise tolerance and
pulmonary artery pressure. However, the effect of long term
oxygen treatment on the position and shape of the oxygen
dissociation curve has not been determined, and as oxygen
transport to the tissues is dependent upon the oxygen
dissociation curve, together with haemoglobin concentration,
arterial oxygen tension and cardiac output, this effect, if one
exists, is important in ascertaining the physiological benefits
of long term oxygen therapy.
Studies carried out by Sagone, Lawrence and Balcerzak (1973)
and Smith and Landaw (1978) suggested that elevated carboxy-
—haemoglobin levels common in smokers, resulted in tissue hypoxia
with adaptive increases in red cell mass, which could be reversed
■—when smoking was discontinued. Many patients with chronic
—oulmonary disease continue to smoke and have elevated carboxy-
laemoglobin concentrations which will increase existing tissue
—lypoxia and secondary polycythaemia. Does a relationship
txist between the degree of secondary polycythaemia in patients
'ith severe chronic bronchitis, and their smoking habits, and
an this be explained by impairment of oxygen transport to
ossible sites within the renal glomerulus or medulla where
rythrogenin is released?
In normal healthy subjects exercise capacity has been
hown to decrease when carboxyhaemoglobin levels are elevated,
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and impairment of maximal oxygen uptake has been shown to
occur at carboxyhaemoglobin levels as low as 4.3%. As carboxy-
haemoglobin levels of 5 - 15% are often encountered in
patients with chronic bronchitis whose exercise tolerance is
already impaired by hypoxaemia, do such carboxyhaemoglobin
levels constitute a significant further impairment of oxygen
transport during exercise?
In many patients, chronic obstructive lung disease is
complicated by chronic carbon dioxide retention, but the exact
mechanism of this retention is still not clear. The removal of
an hypoxic stimulus to ventilation by administration of high
concentrations of oxygen may lead to carbon dioxide retention,
but the classical studies of Christianson, Douglas and Haldane
(1914) showed that, in normal subjects, oxygenation of haemoglobin
at a constant carbon dioxide content also increases the carbon
dioxide tension. The magnitude of this effect can be calculated
—by the equation of Visser (1960):-
CbC02 _ 1 - 0.0215 x 02 capacity
CpC02 (2.244 - 0.422 S02)(8.74 - pH)
where CbC02 = whole blood C02 content
CpC02 = plasma CO2 content
S02 = O2 saturation/100
and 02 capacity is expressed as vol.per vol. of blood
his equation was derived from observations of Van Slyke and Sendroy
1928), made using normal human blood and horse blood, not that
f hypoxic hypercapnic human subjects with chronic bronchitis
nd emphysema. Therefore, as the C.D.H. effect may contribute
0 the hypercapnia seen in these patients, determination of the
—^.gnitude of this effect is required.
The purpose of this study, therefore, was to answer
the following questions
1. Does long term oxygen therapy affect oxygen transport
by changing the oxygen dissociation curve of blood
and other haematologic variables?
2. Can the degree of secondary polycythaemia in
patients with chronic obstructive lung disease be
related to their smoking habits and degree of
tissue hypoxia?
3. Does acute elevation of carboxyhaemoglobin
concentration affect the exercise tolerance of
patients with chronic bronchitis and can this be
related to tissue oxygen supply?
4. Does whole blood CO2 content, calculated using
the equation of Visser (1960), compare with the C02
content measured in the infra red gas analyser
(I.R.G.A.) in normal subjects and patients with chronic
obstructive pulmonary disease, and can this equation
accurately predict the magnitude of the C.D.H. effect?
5. Is the C.D.H. effect in hypoxic, hypercapnic
subjects similar to that in normal subjects, and to
what extent could this mechanism contribute to the
hypercapnia present in some patients with chronic
bronchitis?
6. Is the C.D.H. effect altered by elevated carboxy¬
haemoglobin concentrations, present in many of these
patients who are cigarette smokers?
During the course of the study, marked variations in the
.D.H. effect in normal women posed the following additional
uestions:-
7. Does the C.D.H. effect vary through the
normal menstrual cycle?
8. What are the biochemical mechanisms of





(a) Blood Gas Analysis
All pH and blood gas data were obtained using the IL
model 313 automatic pH/Blood Gas Analyser. Whole blood P02,
PC02 and pH values can be determined simultaneously, and less
than 0.4 ml blood was required for all three measurements.
All three electrode systems were calibrated each morning.
The pH electrode was calibrated using B.D.H. buffer solutions
with pH values of 6.845+ 0.005 and 7.385+ 0.005 at 38°C, and
the calibration was checked at least once during the day. The
P02 and PC02 electrodes were calibrated with two known gas
—mixtures, analysed using the Lloyd Gas Analyser (Gallenkamp),
duplicate determinations of gas samples agreeing to within 0.03%.
—One mixture of approximately 5% C02, 12% 02, balance N2, was
used to set the upper point of the oxygen electrode and the
—lower point of the carbon dioxide electrode, while the other
^;as mixture, which consisted of approximately 10% C02, balance
—19, was used to determine the slope of the oxygen and carbon
—iioxide electrodes. This two-point calibration procedure was
•epeated at least once during the day, but a single-point
:alibration check was carried out between each sample.
Each day the accuracy of the blood gas analyser was checked
<y tonometry of an aliquot of whole blood with a known gas
.ixture, containing approximately 7% 02, 7% C02, balance N2,
ccurately determined with the Lloyd Gas Analyser. In this
—ay the P02 and PC02 of the blood sample became known, and
^"hen introduced into the blood gas analyser, could reveal faults
in electrode response, calibration, temperature or sample
introduction.
The precision of each electrode system was assessed
from 21 consecutive determinations of the same blood sample.
The mean values + 1 standard deviation of these 21 aliquots
were: pH 7.30 + 0.008; ^3.9 + 0.53 mm Hg; and POg
43.5 + 0.37 mm Hg; indicating a greater degree of precision
than that obtained by Weisbrot, Kambli and Gorton
(1974) using the same instrument.
(b) Tonometer
An IL 237 tonometer was used for in vitro equilibration
of blood samples for all research and quality control procedures.
This tonometer is a thin film, open system tonometer consisting
of a thermostatically controlled circulating water bath
containing a gas humidifyer and removable cuvette. By means
of intermittent rotation of the cuvette, the blood is spread
Ln a thin film and brought into close contact with a stream of
lumidified gas. All samples were equilibrated at 37°C with gas
it a flow rate of 350 mls/min for 20 minutes, to ensure complete
equilibration, with minimal haemolysis (Chalmers, Bird and Whitwam,
.974). Comparison of plasma haemoglobin levels before and
fter tonometry of a sample for 20 minutes showed no
hange, indicating haemolysis was not induced by tonometry.
c) Co-oximeter
Oxyhaemoglobin and carboxyhaemoglobin saturations, and
emoglobin concentrations were estimated using the IL 182
o-oximeter. Whole blood is introduced into the apparatus
'rect from the syringe and is automatically haemolysed, mixed,
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thermostated and pumped to the cuvette. The instrument measures
the absorbance of the sample at 548 nm, 568 nm and 578 nm.
where two or more of the haemoglobin derivatives have equal
extinction coefficients. The computational matrix then
applies the Beer-Lambert equation to the data, and solves
three simultaneous equations and finally gives a direct read
out of haemoglobin concentration as g/100 ml, and oxy- and carboxy-
haemoglobin as percentage saturation according to the
following equations
[Hb] total = [Hbr] + [Hb02] + [COHb]
COHb % = JCOHb] lno
[Hbr] +[Hb02] + [COHb]
HbO % - [Hb02 ] 10Q
[Hbr] + [Hb02] + [COHb] uu
where [Hbr] = concentration of reduced haemoglobin
[Hb02] = concentration of oxyhaemoglobin
[COHb] = concentration of carboxyhaemoglobin
The important aspects of these computations is that oxygen
saturation is expressed as the percentage saturation of
:otal haemoglobin with oxygen, as distinct from the percentage
saturation of available haemoglobin with oxygen, which does
lot take account of carboxyhaemoglobin concentration.
For calibration of the IL 182 co-oximeter, freshly drawn
leparinised blood from a non-smoker was used, to ensure low
■.arboxyhaemoglobin levels. Usually blood from a female member
if staff was used as the haemoglobin concentration in females
s close to the mid range of expected haemoglobin values.
The haemoglobin concentration of the sample was accurately
determined by the cyanomethaemoglobin method, and 3 x 10 ml
aliquots of blood were equilibrated with 0^, CO and N2
respectively, and the calibration procedure carried out according
to the manufacturer's instructions. Calibration was necessary
once in 5 - 6 months, but weekly checks were made by
comparing haemoglobin values determined by the cyanomethaemoglobin
method with those determined by the co-oximeter.
The mean value + 1 standard deviation for 21 consecutive
readings of the same sample on the oxyhaemoglobin saturation
channel was 67.1 + 0.34%; on the carboxyhaemoglobin saturation
channel 8.5 + 0.28%; and on the haemoglobin concentration channel
15.0 + 0.09 g/100 ml. These standard deviations compare
closely with those of Maas, Hamelink and Leeuw (1970) for the
same instrument.
(d) Lexington Lex-02-Con
All oxygen contents were measured by the Lexington Lex-Og-Con
—apparatus, which measures total oxygen content from a 20 yl
—sample of whole blood. The oxygen evolved from the blood combines
—,vith a fuel cell which releases a stream of electrons. These
\
f|||lectrons form a current which is propotional to the amount
=£>f oxygen present and the instrument gives a direct digital
-eadout of oxygen content in mis per 100 mis blood.
The fuel cell was checked periodically by comparing oxygen
•.ontent results from the Lex-Og-Con with those from the Van Slyke
[anometric technique, and if necessary the fuel cell was
echarged. Calibration checks were also made daily by
omparing the measured oxygen content of a 20 yl sample of
oom air with the calculated value, taking into account the
SI
temperature, relative humidity and barometric pressure.
Twenty-one measurements of the same blood sample gave
a mean value + 1 standard deviation of 14.6 + 0.38 mis 02/100 ml
blood.
(e) Spectrophotometer
The Unicam SP 1800 Ultraviolet Spectrophotometer was used
for determination of 2,3-diphosphoglycerate concentrations.
This spectrophotometer is a manually operated double beam grating
instrument, which measures the logarithmic ratio of reference
and sample beam light intensities, and displays the absorbance
measurements on a meter with a linear absorbance scale.
The photometric accuracy determined by the manufacturer
was + 1% of full scale on all ranges, and the reproducibility
was also 1% of full scale values on all ranges.
(f) Infra-red Gas Analyser
Whole blood carbon dioxide content was measured by a
new method, modified from that described by Van Kempen and
Kreuzer (1972). An infra-red gas analyser (Grubb Parson Model
IRGA 20), with a range of 0 - 0.5% C02 was used after modifications
had been made. Most of the internal tubing was replaced by
copper tubing to reduce diffusion of carbon dioxide, and a
fan-assisted air circulation system, together with a proportional
temperature controlling system were installed to maintain the
internal temperature at 37°C as the instrument was found to be
sensitive to temperature variations.
A block diagram of the apparatus used to measure whole
■blood carbon dioxide content is shown in Fig. 9. Room air,
-drawn in through soda lime, was pumped at a rate of 50 litres/hour
through the apparatus and then exhausted to air, to flush all
carbon dioxide from the system and zero the instrument. The
circuit was then closed at the two 3-way stopcocks and 0.2b ml
WHOLE BLOOD CO? CONTENT APPARATUS
TRAP TRAP PUMP
Figure 9
Schematic representation of apparatus used to estimate
whole blood CO2 content by the infra-red gas analyser
(I.R.G.A.).
62
of whole blood injected into the cuvette containing 4.0 ml of
0.1 mol/1 lactic acid and an antifoam agent. The carbon dioxide
in the sample was extracted by the lactic acid and constantly
recirculated through the apparatus until a steady reading was
obtained. Results from the infra-red gas analyser were relayed
through a Solartron A220 digital voltmeter to a Teletype printer
which printed readings at 20 second intervals. When readings
had been constant for two minutes, the result was accepted, and
the cuvette was cleaned and prepared for the next sample, and the
circuit opened to flush carbon dioxide from the system. Carbon
dioxide concentrations were read from a calibration graph, drawn
each day, using standard sodium carbonate solutions of
approximately 20, 30 and 50 mmol C02/litre concentration,
determined accurately by the Van Slyke manometric technique.
Calibration of the infra-red gas analyser was checked
periodically by circulating 0.4% C02 in N2, prepared by the
Wosthoff gas mixing pumps, through the instrument, and adjusting
the gain control until the meter reading gave the expected
value. Various concentrations of C02 in N2, ranging from
0 - 0.5% were then circulated through the instrument to check
linearity of the detector.
To assess the accuracy of C02 concentrations determined
by this instrument, 51 samples of blood with carbon dioxide
concentrations ranging from 13 - 35 mmol/litre were analysed using
both the infra-red gas analyser and the Van Slyke manometric
apparatus. In addition, precision was assessed by carrying out
14 repeated estimations on samples of blood containing approximately
14, 25 and 33 mmol C02/litre.
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Assessment of Infra-red Gas Analyser (I.R.G.A.) Performance
The I.R.G.A. detector reading was a linear function of
C02 concentration for values greater than 0.16% C02 (Fig.10 ).
By minimising the closed circuit volume of the instrument, the C0o
sxtracted from the whole blood samples was sufficient in all cases
-to bring the C02 concentration within the instrument into the linear
range of the detector.
The C02 concentrations determined in 51 samples of whole blood
>y the I.R.G.A. and the Van Slyke manometric technique are compared
n Figure 11. The linear regression equation: CC0o3,T ~ „ . s = 0.991 . K . Lr . A . )
Vcvan Slyke) " °'286' n - 51, r - 0.999, P< 0.001,
escribes the relationship, with 95% confidence limits for the popula-
ion of +.0.32 mmol/1. There was no significant difference between
his line and the line of identity.
Tests of reproducibility of 14 replicate samples at three
ifferent levels of C02 gave a standard deviation of 0.13 mmol/1 with
mean of 13.9 mmol/1, a standard deviation of 0.2 mmol/1 with a
san of 23.6 mmol/1, and a standard deviation of 0.22 mmol/1 with a
jan of 33.4 mmol/1, yielding coefficients of variation of 0.9%,
8% and 0.7% respectively.
No cross-sensitivity was detected with the other gases normally





The relationship between I.R.G.A. meter reading and CO2
concentration. The relationship is linear between CO2 concentra¬
tions of 0.16 - 0.50%, and in all determinations of whole blood


























IRGA = 0 99 (Van Slyke) +0-286
95% confidence limits of
± 0 32 mmols/l
n= 51 r = 0 999
8 12 16 20 24 28 32 36 40
WHOLE BLOOD C02 CONTENT BY VAN SLYKE METHOD
(mmol/l)
Figure 11
A comparison of whole blood C02 content estimations measured
using the I.R.G.A. and the Van Slyke manometric apparatus
(r = 0.999, P < 0.001).
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Discussion of the method developed for the determination of
whole blood C02 content
The I.R.G.A. method provides a simple means of measuring
whole blood CC^ content. Results appertaining to the
assessment of this method show that it is capable of measuring
whole blood CC^ content in the range 14 - 35 mmol/1 blood with an
accuracy comparable to that of the Van Slyke manometric technique,
and with a similar degree of precision.
The I.R.G.A. method has additional advantages over the
Van Slyke manometric technique, insomuch as it is not dependent
upon a high degree of operator skill, requiring only the accurate
delivery of the 0.25 ml whole blood sample, which is facilitated
by the use of an accurately graduated glass syringe fitted with
a Chaney adaptor. After the introduction of the whole blood
sample, the analysis will proceed unassisted, the instrument read-out
being recorded by the teletype printer, every 20 seconds.
The analysis time of the IRGA method is marginally faster
than that of the Van Slyke manometric technique, analysing one
sample every 15 minutes, whereas in our laboratory, the Van Slyke
manometric technique requires 15 - 20 minutes to complete an
analysis and to prepare the instrument for the next sample, the
operator's presence being necessary throughout.
Therefore, as the performance of the IRGA compares
favourably with that of the Van Slyke manometric technique, and
also provides greater ease of operation, we feel that this method
of estimating whole blood CC^ content is a marked improvement over
the technique of Van Slyke.
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2. Techniques
(a) Determination of P50
Venous blood was sampled into a 50 ml heparinised
syringe containing a sterile, stainless steel washer which
ensured complete mixing of the sample. Three 5 ml aliquots
of blood were equilibrated in the IL 237 tonometer with
three gas mixtures containing approximately 5% C02, three
different 02 concentrations which yielded oxygen saturations
between 30 - 70%, and balance Ng. At the end of the equilibration
period, the sample was drawn anaerobically into a syringe
containing a mixing washer, and the oxygen and carboxy-
haemoglobin saturations, and the haemoglobin concentration
were determined by the IL 182 co-oximeter. Oxygen content
determinations were made using the Lex-02~Con instrument and
finally blood gas tensions and pH were determined in the IL 313
Blood Gas Analyser.
The P02 values for each sample were corrected to pH 7.40
and base excess zero using the formula of Severinghaus
(1966) which describes the Bohr effect quantitatively:-
Alog P02 = 0.0013 Base Excess -0.48 ApH
By plotting oxygen saturation against the corrected P02 values,
P50 at pH 7.4 and base excess 0 was determined. The P50
was also determined by the Hill plot of log^^-Sa^rat:j'°n^ , . .J * C100 - 02 saturation)
against log P02 (corrected to pH 7.4 and base excess 0),
and the slope of the resulting straight line gave Hill's "n"
a measure of haem-haem interaction.
All measurements for determination of P50 were
carried out within two hours of withdrawal of the sample to
minimise in vitro changes in P50 (Aberman, Cavanilles,
Michaels, Shubin and Weil, 1976).
(b) Determination of Intra-erythrocyctic pH
The red cell pH of arterial and venous samples was
determined by the freeze-thaw technique of Hilpert, Fleischmann,
Kempe and Bartels (1963). Blood was drawn anaerobically
into a 2 ml syringe and centrifuged at 3000 rpm for 15 minutes
at 4°C. The plasma was displaced and the remaining red
blood cells were stored in dry ice (-80^C) for 30 minutes
then thawed at 37°C. The pH was then determined as for
whole blood.
(c) Determination of Packed Cell Volume
The packed cell volume was determined by the micro-
haematocrit technique using the Hawksley microhaematocrit
centrifuge.
(d) Determination of the Christiansen, Douglas, Haldane
(CDH) Effect
A 35 ml sample of venous blood was drawn into a
*
heparinised syringe containing a stainless steel washer
to ensure adequate mixing of the blood. Eight 4 ml aliquots
of blood were equilibrated in the IL 237 tonometer with
various concentrations of C02 in N2, which, when mixed with
air or C>2 in the Wosthoff gas mixing pumps, gave PC02 values
of approximately 20, 40, 50 and 70 mm Hg at two P02 levels
designed to produce blood oxygen saturations of 50 and 100%.
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When equilibration was complete, the samples
were drawn anaerobically into a syringe and measurements
of total carbon dioxide content, oxygen and carbon dioxide
tensions and pH were made. Oxy- and carboxyhaemoglobin
saturations, haemoglobin concentration and the oxygen
content of each sample were also determined.
By plotting the carbon dioxide content of each sample
against the carbon dioxide tension, carbon dioxide dissociation
curves were drawn for oxyhaemoglobin saturations of 50 and
100%. The CDH effect, expressed as the change in carbon
dioxide content at a PC02 of 40 mm Hg as fully oxygenated
blood is reduced to 50% oxygen saturation, was then obtained
as the difference in carbon dioxide content between the two
curves at PCC>2 40 mm Hg (Fig. 29).
(e) Determination of 2,3-Diphosphoglycerate (2,3-DPG)
Concentration
2,3-DPG concentration was estimated by the ultraviolet
method of Sigma (Technical Bulletin 35 -UV). This method
of analysis involves the enzymatic hydrolysis of 2,3-DPG
to 3-phosphoglycerate (3-PGA), catalysed by 2,3-DPG phosphatase,
which is present in purified preparations of phosphoglycerate
mutase, and requires phosphoglycolic acid as a stimulator.
2,3-DPG
2,3-DPG Phosphatase 3-PGA + inorganic phosphate
Phosphoglycolic Acid
The 3-PGA is then coupled with phosphoglycerate kinase and
glyceraldehyde phosphate dehydrogenase to form 3-phospho-
glyceraldehyde.
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3-PGA + ATP Phospboglycerate kinase lj3_DPG + ADP
1 3-DPG + NADH glyceraldehyde phosphate 3-phosphoglyceral-
dehydrogenase dehyde + NAD
The decrease in NADH is proportional to the amount of 2,3-DPG
present initially and by measuring the change in optical
density of the mixture as NADH is oxidised to NAD, the
concentration of 2,3-DPG can be calculated.
Reagents
1. Trichloroacetic acid : 8% w/v solution in distilled
water. Stored at 0 - 5°C.
2. NADH buffer solution : 1 mg NADH dissolved in 8.0 ml
triethanolamine buffer solution. Stable for a few
hours only and stored at 0 - 5°C when not in use.
3. ATP : 500 mg adenosine 5-triphosphate dissolved in
5 ml triethanolamine buffer. Stable for several months
when stored frozen.
4. Glyceraldehyde phosphate dehydrogenase/phosphoglycerate
kinase mixture (GAPD/PGK) from Sigma and stored at
0 - 5°C.
5. Phosphoglycerate mutase enzyme : obtained from Sigma
and stored at 0 - 5°C.
6. Phosphoglycolic acid : 50 mg dissolved in 5 ml distilled
water and stored frozen.
Protein-free Filtrate
A protein-free filtrate of whole blood was prepared
by addition of 1 ml of whole blood to 3.0 ml cold trichloro¬
acetic acid. After thorough mixing, it was centrifuged at
3000 rpm for 15 minutes at 4°C and the supernatant decanted
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off and stored frozen until analysed.
Analysis
Blank and test cuvettes were set up as shown
below:-
Reagent Blank Test
NADH buffer solution 1 ml 1 ml
ATP solution 0.04 ml 0.04 ml
Water 0.1 ml
Protein-free filtrate - 0.1 ml
GAPD/PGK mixture 0.01 ml 0.01 ml
Phosphoglycerate mixture 0.01 ml 0.01 ml
After thorough mixing the optical density at 340 nm was
measured by the Unicam SP 1800 spectrophotometer. 0.04 ml
phosphoglycolic acid was added to each cuvette to start the
reaction and the optical density measured after 30 minutes.
Calculation
Any change in optical density of the blank was
subtracted from the change in the test cuvette, and 2,3-DPG
concentration calculated by: -
ro o AO.D. x (volume in cuvette) , , _ . . ,[2, 3-DPG] -Z7F--—• (volume of originalL ' -J (mMolar extinction coefficient) v N &sample)
= AO.D. x 1.2
6.22 x 0.025
This gives 2,3-DPG concentration in ymoles/ml whole blood, which
is then corrected to ymoles/g haemoglobin.
The accuracy of this method of determination was assessed
by recovery experiments, in which percentage recovery ranged
from 83 - 100%, with a mean of 90%. This result was
accepted, as the 2,3-DPG salt used in the tests was not
the most pure, so a larger error was to be expected. The
mean + 1 standard deviation of 10 determinations on the
same sample was 2.41 + 0.02 ymoles 2,3-DPG/ml blood
(P. Tweeddale, Personal Communication).
CHAPTER 4
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Study of Long Term Oxygen Therapy
Subjects and experimental design
The patients (11 women, 15 men) were aged between
42 - 68 years at the start of the study, and all suffered
from hypoxic cor pulmonale secondary to chronic bronchitis
and emphysema, diagnosed from the history, clinical
examination, chest x-ray and the presence of severe airways
obstruction (FEV-^ q 0.20 - 1.35, mean 0.58 + 0.23). At the
start of the study all were hypoxaemic (arterial P02 44 - 60
mm Hg) and hypercapnic (arterial PC02 46 - 67 mm Hg) at rest,
breathing air, and had had one or more documented episodes
of cor pulmonale. The patients were clinically stable
and without significant change in arterial blood gases, FEV^ ^
or body weight for three weeks prior to the first assessment.
This assessment included measurement of P50,„ Hill's
(7.4)'
'n', oxygen capacity, 2,3-DPG concentration, carboxyhaemoglobin
saturation, haemoglobin concentration, packed cell volume,
arterial and venous pH of whole blood and red cells, and
arterial blood gases.
On entry to the study, the patients were randomised;
13 were designated as control subjects who would receive
no long term oxygen therapy and 13 were designated as treated
subjects who would receive long term oxygen therapy for 15
hours per day. Controlled oxygen therapy was provided through
nasal prongs at a flow rate of 2 L/minute, designed to
raise the arterial oxygen tension to over 60 mm Hg (Leggett,
Cooke, Clancy, Leitch, Kirby and Flenley,1976).
The progress of the patients was followed at
routine clinic visits and at assessment after 12, 24 and
36 months of the study, when all the above measurements were
repeated.
Statistical comparisons of mean values between
the two groups of patients were carried out using
unpaired 't' test, and comparisons within subjects by
paired 't' test.
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'.esults appertaining to the study of long term domiciliary oxygen
herapy
There was no significant difference in age, severity of
irways obstruction, red cell mass, or mean pulmonary artery pressure
t the start of the study, between those subjects designated as
ontrol patients, and those who were to receive long term oxygen
-herapy (Table la,b). In addition, there was no significant difference
-a average values of arterial blood gases, extracellular and intra¬
cellular pH, haemoglobin concentration, packed cell volume ,(P . C. V 3, mean
Drpuscular haemoglobin concentration (M.C.H.C.), in vitro P5q^7
Ill's n, 2,3-DPG concentration and carboxyhaemoglobin levels
jtween the two groups at the start of the study, nor after one year
! therapy (Table 2). However, after two years of the study, the
;an haemoglobin concentration and packed cell volume in the patients
■ceiving oxygen therapy (13.6 + 1.4 g/dl and 45.0 + 4.8 ml/dl
spectively) were significantly lower (P<0.05) than those of the
-=ntrol group patients (mean haemoglobin concentration 16.0 + 1.9 g/dl
d P.C.V. 52.0 + 5.2 ml/dl), this trend continuing at the third year
-cessment, when those patients receiving oxygen therapy again
—nonstrated a lower mean haemoglobin concentration (13.1 + 1.6 g/dl)
—i packed cell volume (44 + 5.3 ml/dl) than the control group
;ients (mean haemoglobin concentration 17.4 + 0.4 g/dl, mean
:.V. 57 + 1.0 ml/dl). (P<0.01, P<0.02 respectively.)
The average P50^7 value determined in the patients
.eiving long term oxygen therapy did not differ significantly from
t in the control group patients until the third year of the study,
n the mean P50^7 ^ in those patients receiving oxygen therapy
.3 + 2.1 mm Hg) was significantly lower (P < 0.05) than that in the
surviving control group patients (30.1 + 0.8 mm Hg), but there
no significant difference in the shape of the oxygen dissociation
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curve, indicated by the average value of Hill's n, between the
-two groups, at any time during the study.
Throughout the study, 2,3-DPG concentrations were higher in
-the control group than in the "treated" group, but differences
-in the mean values did not reach statistical significance. Mean
-arterial blood gas and extracellular and intracellular pH
-neasurements obtained while the patients were breathing air, at
•est, did not differ significantly between the control and "treated"
jatients during the study,, and there was no difference in MCHC values.
Of the initial 13 patients who were given domiciliary oxygen
;herapy, seven survived for three years or longer. By allowing
;ach of these patients to serve as his own control, the effect of
>xygen therapy within this group can be seen. The mean values of
leasurements made in these seven patients before and one month,
me year, two years and three years after beginning oxygen therapy
re shown in Table 3 .
Mean P50^y determined after one month of oxygen therapy,
28.0 + 2.1 mm Hg) was significantly higher (P<0.02) than the mean
re-treatment Pso^y (26.8 + 1.2 mm Hg) , but the mean Pso^y 4)
etermined after one, two and three years did not differ significantly
rom the mean pre-treatment value inthose seven patients. In
ddition, the shape of the oxygen dissociation curve, indicated by
ill's n, did not change significantly during the study.
No other variable showed significant change from the pre-
—reatment value after only one month of oxygen therapy. After 12
}nths of domiciliary oxygen therapy, however, 2,3-DPG concentration
—13.6 + 3.24 ymoles/gHb) was significantly lower (P<0.05) than the
—litial mean value (15.91 + 1.75 ymoles/gHb), and this decrease
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continued, as shown by the mean concentration at the second year
-assessment (13.43 + 2.21 ymoles/gHb). However, by the end of the
-study, mean 2,3-DPG concentration began to rise again, and at the thir
-/ear assessment was 14.78 + 3.47 ymoles/gHb, which was not
-significantly different from the initial value (Fig.12 ).
Haemoglobin concentration after one year of oxygen therapy,
;i3.8 + 2.0 g/dl),was significantly lower (P<0.05) than the mean pre
;reatment level (15.7 + 1.7 g/dl) and this reduction was maintained
-at the second (P<0.02) and third year (P<0.01) assessments
;i3.6 + 1.4 g/dl and 13.1 + 1.6 g/dl respectively) (Fig. 13). The
-nean packed cell volume was associated with the changes in
laemoglobin concentration throughout the study, being significantly
Lower than the average pre-treatment value (53.5 + 7.8 ) at the
'irst year (45.1 + 10.0, P<0.025), second year (45.0 + 4.8 ,
5 <0.02) and third year assessments (44.0 + 5.3 , P<0.005) (Fig. 14).
Because the changes in packed cell volume were associated
fith the changes in haemoglobin concentration, there was no
significant change in the M.C.H.C. during the course of the study.
Arterial PO2, measured while the patients were breathing air,
'as not significantly different from the initial value (54.3 + 5.3
-im Hg) after one year of oxygen therapy, but thereafter the degree
f hypoxaemia appeared to increase, as judged by arterial P02
easurements made at the second and third year assessments (46.6 +
.6 mm Hg, P<0.02, and 46.0 + 10.0 mm Hg, P < 0.10 respectively)
Fig. 15). However, the mean arterial PC02 and pH measurements
id not differ from the initial pre-treatment values during the
tudy.
As only two patients from the control group were alive
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Figure 12
Mean 2,3-DPG concentrations (+ 1 S.D. in the 5 control group
patients who survived for at least 2 years of the study (o), and
in the 7 O2—therapy patients who survived for 3 years of the
study (•). Measurements in the control group were made initially,
and after 1 and 2 years. Measurements in the 02—therapy group
were made initially and after 1 month, 1, 2 and 3 years.
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Figure 13
Mean haemoglobin concentrations (+ 1 S.D.) in the 5 control group
patients who survived for at least 2 years of the study (o),
and in the 7 02-therapy patients who survived for 3 years of the
study (•). Measurements were made initially and after 1 and 2
years in the control group, and initially and after 1 month,
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Figure 14
Mean P.C.V. (+ 1 S.D.) in the 5 control group patients who survived
for at least 2 years of the study (o), and in the 7 C>2~therapy
patients who survived for 3 years of the study (•). Measurements
were made initially and after 1 and 2 years in the control group,and initially and after 1 month, 1, 2 and 3 years in the 02-therapy
group.
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Figure 15
Mean arterial PO2 (+ 1 S.D.) in the 5 control group patients who
survived for at leait 2 years of the study (o), and in the 7 O2-
therapy patients who survived for 3 years of the study (•).
Measurements were made initially and after 1 and 2 years in the
control group, and initially and after 1 month, 1, 2 and 3 years
in the O2-therapy group.
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occurring in the control group during the study was carried
out on results from the five patients surviving at the second
year assessment. During the two years, the only variable to
change significantly in these patients was Pso^-y which fell
significantly (P<0.02), from the mean pre-treatment value (27.0 +
1. 9 mm Hg) after the first year (26.5 + 0.5 mm Hg), but
increased again to the pre-treatment value after two years
(27.2 + 1.5 mm Hg).
All other variables in the control group did not change
significantly during the study, mean values of 2,3-DPG, haemoglobin,
packed cell volume and arterial PO^ during the study being shown
in Figs. 12, 13, 14 and 15 and Table 3.
From serial measurements of carboxyhaemoglobin levels in
those patients receiving oxygen therapy, it was apparent that
six of the eleven patients alive after one year of the study
continued to smoke, as their carboxyhaemoglobin levels were
repeatedly greater than 4%. Allowing each patient to serve as
his own control, differences in response to 12 months of oxygen
therapy, between the smokers and non-smokers, can be seen. In the
five non-smoking patients, the mean haemoglobin concentration
after one year of oxygen therapy (13.2 + 1.45 g/dl) was
significantly lower (P<0.01) than the pre-treatment mean in those
patients (15.8 + 1.69 g/dl). However, although the mean haemoglobin
concentration in the six patients who continued to smoke was lower
after one year of oxygen therapy (14.9 + 2.11 g/dl) than it was
at the start of the study (16.21 + 2.49 g/dl), the fall in
haemoglobin concentration was less dramatic (P<0.10) (Fig. 16).
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Haemoglobin concentration determined before, and 12 months after
beginning long term 02 therapy in 5 non-smoking (o), and 6
smoking patients (•) with chronic bronchitis.
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non-smoking patients (from 53.6 + 6.68 initially, to 42.2 + 4.20
after one year) was highly significant (P <0.001), but the fall
in mean packed cell volume in the smoking patients (from 54.7 + 9.35
initially, to 49.9 + 10.5 after one year) only reached statistical
significance at the 10% level (Fig- 17)-
The concentration of 2,3-DPG did not change significantly
after one year of oxygen therapy in those patients who continued to
smoke (mean pre-treatment value 15.21 + 1.61 ymoles/gHb, mean value
after one year 15.18 + 2.28 ymoles/gHb), but in the non-smoking
patients, mean 2,3-DPG concentration fell markedly (P<0.10)
from the pre-treatment value (15.85 + 1.90 ymoles/gHb) after one
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Figure 17
Packed cell volume determined before and 12 months after,
beginning long term O2 therapy in 5 non-smoking (o), and' 6
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Figure 18
2,3-DPG concentration determined before, and 12 months after
beginning long term 02 therapy in 5 non-smoking (o) and
6 smoking patients (•) with chronic bronchitis.
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Discussion of results appertaining to the study of long
term oxygen therapy
The results of this controlled study of long term oxygen
therapy confirm and extend observations made in previous
uncontrolled studies of oxygen therapy in patients with chronic
obstructive lung disease. Viewing each patient who received
oxygen therapy as his own control, significant reductions in
haemoglobin concentration and packed cell volume noted by
previous investigators (Chamberlain and Millard, 1963; Block,
Castle and Keitt, 1974) were confirmed in this study, but the
beneficial effect of oxygen becomes more convincing when
haemoglobin concentration and packed cell volume measurements
are compared with those in the matched control patients who showed
no reversal of the compensatory polycythaemic response. This
reduction of haemoglobin concentration in patients receiving
oxygen therapy would necessarily reduce the oxygen capacity of
the blood, but this decrease is offset in arterial blood by
the increased oxygen saturation afforded by oxygen therapy. Thus,
as the mean haemoglobin concentration falls from 15.7 g/dl to
13.1 g/dl, as in patients in this study, the oxygen capacity
is reduced from 21.0 mls/100 ml blood to 17.6 mls/100 ml blood
(assuming an oxygen combining power of 1.34 mls/gHb), but if
the mean oxygen saturation is raised from 80 - 92% by oxygen
therapy, the arterial oxygen content will only decrease by
0.6 mls/100 ml blood, from 16.8 to 16.2 mls/100 ml blood.
Similarly, when each patient receiving oxygen therapy serves
as his own control, serial measurements of 2,3-DPG reveal the
reversal of another compensatory phenomenon. A number of authors
have suggested that 2,3-DPG concentration increases in response
Aucutt
to the hypoxic stimulus (Lenfant, Ways/and Cruz, 1969; Oski,
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Gottlieb, Miller and Delivoria-Papadopoulos, 1970; Oski, Gottlieb,
Delivoria-Papadopoulos and Miller, 1969), but this has not been
supported by other studies (Edwards and Canon, 1972; Guy,
Kazura, Bromberg and Balcerzak, 1971). The mean 2,3-DPG
concentration in patients in this study was at the upper limit
of the normal range in our laboratory (12.44 - 16.28 ymoles/g haemo¬
globin) at the beginning of the study. However, after one year
of oxygen therapy the 2,3-DPG concentration in the patients
receiving oxygen treatment had fallen significantly to within the
normal range, and it remained at this level for two years. This
observation confirms that of Block et al (1974) who found a
slight decrease in 2,3-DPG concentration in patients with chronic
airways obstruction during a four week period of oxygen therapy,
although these changes did not reach statistical significance.
The fall in 2,3-DPG concentration was not reflected by an
increase in the oxygen affinity of the blood, assessed by
P50^ measurements. However, using data from Arturson, Garby,
Robert and Zaar (1974), the theoretical effect of this decrease
in 2,3-DPG concentration on P50^ ^ could be calculated. These
authors determined ligand correction factors for A log PO2 (mm Hg)/
Alog DPG (mmole/1 red cells) for constant oxygen concentration,
pH and PCOg. Their calculations, therefore, neglect the effect of
changing 2,3-DPG concentrations on red cell pH, but as our results
show little change in the red cell pH during the study, these
correction factors serve as a close approximation. For an
oxygen saturation of 50%, pH 7.40 and PC02 40 mm Hg, the ligand
correction factor, Alog P02/ Alog DPG, is 0.31, If this is then
applied to the change in mean 2,3-DPG concentration observed
after one year of oxygen therapy, the change in P02 at 50%
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oxygen saturation and pH 7.4 (i.e. P50^ would be only
0.9 mm Hg. When variations normally present in blood gas, pH and
oxygen saturation measurements are considered, it is not too
surprising that no fall in P50^ ^ was detected.
The determination of in vitro P50^y ^ involves the use of
correction factors to standardise the measurement to a pH 7.40,
PCO2 4:0 mm Hg and zero base excess. The formula of Severinghaus
(1966) was employed for these corrections, and is approximated
by: Alog PO2 = -0.48 A pH + 0.0013 Base Excess. This formula
corrects for deviations in pH from 7.40 produced by respiratory
and metabolic causes. Inherent in the use of this correction
factor is the assumption that all individuals respond in an
identical way to changes in pH and base excess. This assumption
will necessarily introduce errors into the calculations. In
addition, the use of Severinghaus's correction formula assumes
that the extracellular pH mimics pH changes within the red cell,
for it is the latter which influences oxygen affinity. By
simultaneous measurements of extra- and intracellular pH in this
and other studies (Fairweather, Walker and Flenley, 1974;
Tweeddale, Leggett and Flenley, 1977), this assumption appears
justified.
From measurements of P50^ and Hill's 'n', it appears
that long term oxygen therapy has no significant effect on the
—position or shape of the oxygen dissociation curve in patients
■vith chronic airways obstruction. In both the control group
—patients and those patients receiving oxygen therapy, the mean
D50^ determined before and during the study remained within
;he normal range for subjects of the same age group (Tweeddale,
jeggett and Flenley, 1976). This is contrary to the findings of
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Block et al (1974), who investigated the rate of oxygen release
from haemoglobin and found it to be increased in patients with
chronic airways obstruction when breathing air, but returned
to normal after four weeks of domiciliary oxygen therapy. The
findings of Block et al, in part,support those of Lenfant et al
(1969), who found raised P50^7 values in patients with chronic
airways obstruction, complicated by polycythaemia, but Fairweather
et al (1974) and Tweeddale et al (1977) were unable to demonstrate
-any difference in P50^7 ^ between normal subjects and patients
with obstructive lung disease.
Similarly, the slope of the oxygen dissociation curve,
sxpressed as Hill's 'n' was unaffected by oxygen therapy, and remained
—lormal in both groups of patients during the study, suggesting that
laem-haem interaction is not altered by hypoxaemia.
Serial measurements of arterial blood gases indicate that
Long term oxygen therapy does not improve the underlying lung
jondition in patients with chronic bronchitis, as arterial PC^,
—leasured while breathing air, did not improve in those patients
•eceiving oxygen treatment, nor did it differ significantly from
leasurements made in the control group patients during the study,
owever, further results from the whole M.R.C. trial of long
erm oxygen therapy (In Press, October 1980) show that long term
xygen administration appeared to prevent a further fall in the
rterial PO2 when the patients were breathing air. Measurements
f arterial PC02 indicate that oxygen, administered at a flow rate
—f 2 litres/minute for 15 hours in the day did not cause chronic
02 retention.
The results of this study indicate that domiciliary oxygen
herapy can reverse a number of compensatory responses caused by
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hypoxaemia. However, a comparison of the effectiveness of 12
months of oxygen therapy in patients who continued to smoke and
those who discontinued this habit on commencement of oxygen therapy,
shows an incomplete response to oxygen therapy in the smokers,
and confirms the findings of Foster, Corrigan and Goldman (1978).
Many authors have demonstrated above average levels of red cell
mass, haemoglobin concentration and haematocrit resulting from
impaired tissue oxygen supply in otherwise normal healthy subjects
who smoked (Sagone, Lawrence and Balcerzak, 1973; Sagone and
Balcerzak, 1975; Smith and Landaw, 1978). On the basis of these
results, it is likely that oxygen therapy would be less efficient
in improving tissue oxygen supply, and removing the erythropoietic
response in patients with chronic bronchitis and secondary
polyeythaemia, if the patient continued to smoke, and thereby
maintained the low oxygen combining power of the blood, and a
comparison of the effectiveness of oxygen therapy in the non-smoking
and smoking patients substantiates this hypothesis by showing an
incomplete reversal of elevated levels of haemoglobin concentration
—and packed cell volume after 12 months oxygen therapy in the patients
—who continued to smoke.
Sagone et al (1973 and 1975) and Smith and Landaw (1978) found
—10 compensatory rise in 2,3-DPG concentration in subjects with
carbon monoxide-induced hypoxaemia, but our results show that the
;all in 2,3-DPG concentration, observed in the non-smoking patients
(.fter 12 months of oxygen therapy, did not occur in those patients
'ho continued to smoke. Existing theories of 2,3-DPG regulation
annot explain this lack of response to oxygen therapy amongst the
moking patients, for there was no significant difference in the pH
f the blood between the smokers and non-smokers which may have
ltered the activity of enzymes in the Rapoport-Leubering shunt,
or was there a greater amount of reduced haemoglobin in the smokers,
producing an increase in potential 2,3-DPG binding sites,
thereby allowing increased synthesis of the free compound.
Similarly, Dinman, Eaton and Brewer (1970) who found
2,3-DPG levels in humans rose after acute exposure to carbon
monoxide, but remained stable in control subjects, were unable
to explain their results using existing theories of 2,3-DPG
regulation, and suggested the existence of a hypoxia-driven
stimulation of 2,3-DPG synthesis, independent of the deoxy-
haemoglobin-binding mechanism, and the results of our
investigation appear to support this suggestion.
CHAPTER 5
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Study of the Role of Carboxyhaemoglobin in the Genesis of Secondary
Polycythaemia in Chronic Bronchitis
Subject's and experimental design
Forty-seven patients (20 women, 27 men) with chronic
hypoxic cor pulmonale were studied. They were all hypoxaemic
(arterial P02 43 - 62 mm Kg), and all, except six, were
hypercapnic (arterial PC02 33 - 68 mm Hg) when breathing air
at rest, and all had severe airways obstruction (FEV^ Q 0.6 + 0.2 L).
The patients were in a stable clinical state when studied,
as judged by constant weight, FEV^ q and arterial blood gas
tensions over a four week period prior to the study.
Seventeen patients were classified as non-smokers on
the basis of their smoking history, together with measurements
of their carboxyhaemoglobin levels. A carboxyhaemoglobin
saturation below 4% was accepted as evidence that the patient
was no longer smoking, and patients were only classified as
non-smokers if they had not smoked for two years prior to
the study.
The degree of secondary polycythaemia was assessed by
red cell mass and plasma volume determinations using IV
51 131
autologous Cr labelled red blood cells and I labelled albumin
(Hurley 1975), and oxygen transport was assessed by measurements
of the P50 and haemoglobin concentration, together with the
arterial blood gas tensions and pH. From this data the
—arterial oxygen saturation was determined in two ways:
firstly, by assuming a normal oxygen dissociation curve in
—the absence of any carboxyhaemoglobin, the oxygen saturation
zould be obtained directly from the Severinghaus standard
Dxygen dissociation curve (P50^7 ^ = 26.6 mm Hg), corrected
"for arterial pH; secondly, the oxygen saturation was
—letermined using the oxygen dissociation curve, obtained for
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each patient. This curve, which was usually constructed
during the period of hospital admission when the carboxy-
haemoglobin levels in all patients were low, was corrected
to take into account the effect of the average carboxy-
haemoglobin levels present in the patients at the frequent
outpatient visits (Collier, 1976), and the oxygen saturation
corresponding to the arterial oxygen tension and pH was
determined. This saturation can be expressed in two ways: as
a percentage of total haemoglobin (S02T), or as a percentage
of available haemoglobin (SOgA), the latter expression excluding
that haemoglobin in combination with carbon monoxide. In
non-smokers where carboxyhaemoglobin levels are low, there
is little difference, numerically, between SOgT and S02A.
However, as carboxyhaemoglobin levels increase, the difference
widens. Using oxygen saturation, expressed as a percentage
of total haemoglobin concentration, arterial oxygen content
(Ca02) was estimated:-
Ca0o = S°2T x 0„ capacity2 100 A
where 02 capacity = Hb (g/dl) x 1.34
The probable level of oxygen content in the renal venous blood
(Cv02) was then calculated on the assumption that renal
arterio-venous oxygen content difference was either 2 or 5
=ml 02/100 ml blood. This renal venous oxygen content was
then expressed as saturation (Sv02):-
Sv°2 = xlOOz (^capacity
This saturation value could then be used to derive the renal
-venous oxygen tension (PV0o) using the corrected oxygen
dissociation curve.
Significance of differences of mean values between the smokers
=and non-smokers were determined by the unpaired 't * test.
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Results appertaining to the study of polycythaemia in chronic
hypoxic cor pulmonale
There was no significant difference in age, resting arterial
blood gas tensions or pH between those patients who smoked and
those who were non-smokers (Table 4 ). Similarly, there was
no significant difference between mean arterial oxygen saturation
measurements in the two groups, when expressed as a percentage
of the available haemoglobin (SC^A). However, arterial oxygen
saturation expressed as a percentage of the total haemoglobin
(S02T, which includes the COHb concentration) was significantly
higher (P<0.02) in the non-smoking patients (mean 83.9 + 4.2%)
than in the smokers (mean 80.1 + 5.4%) and mean red cell mass
measurements were significantly lower (P <0.001) in the non-smokers
(mean 29.2 + 4.1 mls/kg) than in the smokers (mean 42.4 + 8.0 mls/kg)
(Table 5 ).
In those patients who smoked, there was a significant linear
relationship between red cell mass and arterial oxygen saturation
when determined assuming a normal oxygen dissociation curve
with no COHb present (r = -0.38, P<0.05), but as shown in Fig.19
there was wide variability in the polycythaemic response to oxygen
saturation determined in this way. This relationship improved
only slightly when SOgA, determined after correction of the
measured oxygen dissociation curve for the prevailing mean COHb
level in each patient was used (r = -0.40, P <0.05). However,
when SOgA was replaced by S02T, which reflects the lower combining
ability of haemoglobin and oxygen in the presence of COHb, the
correlation improved markedly (r = -0.56, P<0.005), indicating
a strong inverse relationship between red cell mass and S02T
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—Figure 19
Red cell mass is plotted against arterial oxygen saturation
calculated assuming a normal oxygen dissociation curve with 0%
10Hb, for non-smoking (o) and smoking patients (•) with
chronic bronchitis. The regression line relates to the smokers
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Figure 20
Red cell mass is plotted against arterial oxygen saturation,
determined taking the mean COHb level in each patient into account,
and expressed as a percentage of the total haemoglobin concentration
(SO2T) for the non-smoking patients (o), and the smoking
patients (•) with chronic bronchitis. The regression line relates
to the smokers (r = -0.56, P<0.005), and the mean value + 1 S.D.
to the non-smokers.
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was found between red cell mass and oxygen saturation when
determined assuming COHb levels of 0% (r = 0.01, P>0.10)
(Fig. 19 ). Nor did a relationship between red cell mass and
oxygen saturation emerge in the non-smokers when COHb levels were taken
into account and oxygen saturation was expressed as S02A
(r = 0.02, P >0.10) or S02T (r = 0.08, P *0.10) (Fig. 20 ).
The data presented in Figs. 19 and 20 not only indicates clearly
different relationships between red cell mass and arterial
oxygen saturation in the smokers and non-smokers, but also that
the smokers tended to have a greater degree of polycythaemia
for any given level of arterial oxygen saturation than did the
non-smokers.
When red cell mass was related to the mean prevailing
CoHb level in each patient, smoking and non-smoking, a
significant linear correlation emerged (r = 0.64, P<0.001).(Fig.21)
There was no significant difference in renal venous
oxygen tensions, calculated using the measured P50^ ^ and
assuming an arterio-venous oxygen content difference of 2 mls/100
ml blood, between those patients who smoked (mean Pv02 = 39.3 +
4.0 mm Hg) and the non-smoking patients (mean Pv02 = 43.0 + 3.8).
However, assuming an arterio-venous oxygen content difference
of 5 mls/100 ml blood, the renal venous oxygen tension in the
non-smokers (mean value 33.2 + 3.2 mm Hg) was significantly
higher (P<0.05) than that in the smokers (mean value 30.2 + 3.0
mm Hg) (Table 5 ).
Using data from all patients a significant negative linear
relationship emerged between red cell mass and renal venous oxygen
tension, calculated assuming an arterio-venous oxygen content
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Figure 22
Red cell mass is plotted against renal venous oxygen tension,
calculated assuming an arterio-venous 02 content difference of
2 ml 02/100 ml blood in non-smoking (o), and smoking patients (1
with chronic bronchitis (r = -0.48, P<0.005).
the relationship improved, when red cell mass was related
to the renal venous oxygen tension calculated assuming an
arterio-venous oxygen content difference of 5 ml/100 ml
(r = -0.51, P < 0.001) (Fig. 23 ).
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—figure 23
—led cell mass is plotted against renal venous oxygen tension,
calculated assuming an arterio-venous 02 content difference of
> ml O2/IOO ml blood in non-smoking (o) and smoking patients (•
/ith chronic bronchitis (r = -0.51, P<0.001).
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Discussion of results appertaining to the study of polycythaemia
in chronic hypoxic cor pulmonale
Previous studies carried out by Weil, Jamieson, Brown and
Grover (196 8), Chan(1969 ), and Harrison (1973), established a relationship
between polycythaemia and hypoxaemia both in subjects at altitude
and in patients with chronic bronchitis. However, the authors
failed to take into account the smoking habits of the subjects
when determining the arterial oxygen saturation, and assumed each
subject had a normal oxygen dissociation curve and low carboxy-
haemoglobin level. In our experience, patients who smoke may
have carboxyhaemoglobin levels as high as 15%, and it is
therefore possible that by omitting to take this into account,
gross inaccuracies in the determination of oxygen saturation may
have resulted, leading to wide variations in the response to
hypoxaemia.
The results obtained in this study confirm the negative
relationship between red cell mass and arterial oxygen saturation,
as determined by the authors mentioned above, assuming no carboxy¬
haemoglobin, but our results showed this relationship was very
variable (Fig. 19 ). However, by taking into account the
carboxyhaemoglobin levels normally present in these patients,
much of the variation was removed, and the relationship between
red cell mass and arterial oxygen saturation improved.
The data represented in Figure 20 indicates that for any
given level of arterial oxygen saturation, values of red cell
mass in the patients who smoked are greater than those found in
the non-smoking patients. This observation suggests that the
carboxyhaemoglobin formed by combination of haemoglobin with
carbon monoxide present in cigarette smoke, enhances the
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polycythaeraic response to hypoxia by its dual effect on the
haemoglobin molecule, that is by lowering the oxygen carrying
capacity of haemoglobin, and by increasing the affinity of
haemoglobin for oxygen, thus impairing tissue oxygen supply.
This suggestion is strongly supported by the close correlation
observed between red cell mass and carboxyhaemoglobin levels
(Fig. 21 ). Vanuxem, Guillot, Fornaris, Weiller and Grimaud
(1977), and Foster, Corrigan and Goldman (1978) reached a
similar conclusion from their work in patients with chronic
respiratory insufficiency, but they assessed polycythaemia from
haemoglobin concentration and haematocrit results, which may not
reflect the extent of the polycythaemic response as accurately as
measurements of red cell mass, as concomitant changes in plasma
volume may conceal the extent of polycythaemia.
Having observed a relationship between red cell mass and
arterial oxygenation in the smoking patients, we turned our
attention to the mechanism of this response. The main site of
erythrogenin release was identified as the kidney by Jacobson,
Goldwasser, Fried and Plzak (1957), and several studies have shown
that the isolated organ increases erythropoietic activity when
perfused with hypoxic blood (Adamson and Finch, 1975). Our
results show that the oxygen saturation of arterial blood appears
to be a major determinant of erythropoietic activity, but
results from Adamson (1970) and Miller and co-workers (1973) suggest
that erythropoietic activity also depends upon the haemoglobin
affinity for oxygen. This would suggest that it is the supply of
oxygen to the tissue that is the most important determinant of
erythrogenin release, and as oxygen supply depends upon several
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'actors in addition to arterial oxygen saturation, the relationship
letween red cell mass and arterial oxygen saturation is probably
n oversimplification.
However, measurements of some of the other factors involved
n oxygen delivery, such as P50^ haemoglobin' concentration,
nd pH, together with reasonable assumptions as to the oxygen
ombining power of blood, and the renal arterio-venous oxygen
ontent difference, allowed us to estimate the tissue PC^ within
he kidney. As an arterio-venous oxygen content difference of
ml/100 ml blood (which probably represents that across the
-enal medulla (Hollenberg, 1979)) gave the greater significant
inear relationship, it may imply that this is the site where
-xygen supply is critical for the release of erythrogenin. The
-«ygen supply to this site would be limited in those patients
ith an elevated carboxyhaemoglobin level, due to the greater
■^cygen affinity of haemoglobin and the lower oxygen capacity
■£ the blood, and together these factors could account for the
-ceater polycythaemic response in this group.
There, remains some variability in response, which is still
—lexplained. Some of this variability may result from our
-^sumption of a constant arterio-venous oxygen content difference
I.e. renal blood flow) in all the patients. In addition,
—lvestigations into oxygen supply during exercise (King, Cooke,
iitch and Flenley, 1973) and during sleep (Douglas, Calverley,
>ggett, Brash, Flenley and Brezinova, 1979) have revealed increases
i the severity of hypoxia in such patients, which may lead to an
icrease in red cell mass, producing a greater polycythaemic
'sponse than would be expected from results obtained in these
tients, when awake and at rest, which may account for some of
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the variation. However, despite some variability, the results
of this study strongly suggest that carboxyhaemoglobin, produced
by the combination of haemoglobin with carbon monoxide from
cigarette smoke, plays an important role in enhancing the
polycythaemic response to hypoxia in patients with chronic
obstructive lung disease, by limiting the supply of oxygen to
a site within the kidney. Although our results indicate the
renal medulla as the most likely site of erythrogenin release,
more direct measurements of P02 within this region are required
to substantiate this hypothesis.
CHAPTER 6
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Study of the effect of elevated COHb saturations on oxygen
;ransport and exercise tolerance in chronic bronchitis and
;mphysema.
Subjects and experimental design
Nine patients (3 women, 6 men) with chronic bronchitis and
;mphysema were studied. The patients had severe airways
tbstruction (FEV^ q 0.35 - 1.90 L) and were hypoxaemic at rest
arterial PC>2 43.0 - 59.0 mm Hg) . Each patient was clinically
;table when studied, and although some of the patients smoked,
hey were asked to refrain from smoking on the day of the study.
11 studies were carried out in the afternoon.
Venous blood samples were taken for determination of
50(7 4)' 2,3-DPG concentration, haemoglobin concentration,
arboxyhaemoglobin saturation and venous pH of whole blood
nd red cells, before the start of the study, and again after
-nhalation of 0.02% carbon monoxide over 15 minutes. Additional
lood samples were taken for the determination of 2,3-DPG
oncentration and extra-and intra-cellular pH at the end of
xercise both before and after the experimentally induced elevation
f carboxyhaemoglobin. Arterial blood gases, 02 saturation and pH were
lso determined at the start of the study.
The exercise tolerance test employed was that of McGavin,
upta and McHardy (1976). The subjects walked on the level, at
leir own pace, for 12 minutes, and the distance walked was recorded,
iring each walk, the patients received either air or oxygen
—t a flow rate of 2L/minute via nasal cannulae from a cylinder
transported behind the patient. The patient was not aware of
lich gas was being administered.
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Each patient was studied on two occasions and completed
four walks on each occasion: breathing air then oxygen before
elevation of carboxyhaemoglobin, and air then oxygen after
elevation of carboxyhaemoglobin, with 20 minute rest periods
between each walk. On the second occasion, the order of air
and oxygen administration was reversed, both before and
after carbon monoxide inhalation.
In 14 of the 18 studies, arterial oxygen saturation at rest
and at the end of each exercise period was determined using the
-Hewlett Packard Ear Oximeter. This instrument gave a direct
-estimation of oxygen saturation at low carboxyhaemoglobin
-saturations, but at high carboxyhaemoglobin saturations, a
correction factor had to be applied to the reading to give
the oxygen saturation, which was expressed as a percentage of
-the total haemoglobin (SO2T) (Douglas, Brash, Wraith, Calverly,
Leggett, McElderry, Flenley, 1979). The correction factor is
described by the equation:
oximeter reading = 0.987S02 + 0.628COHb - 1.465
where SO2 = saturation of total haemoglobin with Og
Jsing arterial saturation, arterial oxygen content (CaC^) was
calculated:-
SO T
Ca0o = 2 x Or, Capacity
100
where O2 capacity is calculated as:
02 capacity = Hb.(g/dl) x 1.34 where 1.34 = oxygen combining
power
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he femoral venous oxygen content (Cv02) was then calculated
n the assumption that femoral arterio-venous oxygen content
■ifference was either 7 or 10 ml oxygen/100 ml blood. This
smoral venous oxygen content was then expressed as
saturation (Sv02);-
CvC>2
Sv0o = -pr r—— x 1002 02 capacity
lis saturation was then converted to femoral venous oxygen
insion using the oxygen dissociation curve determined for each
itient, and corrected to the venous pH.
The paired t-test was used to assess statistically
gnificant changes of mean P50^y 4^, 2,3-DPG concentration,
id extra-and intra-cellular pH after elevation of carboxyhaemoglobin
d at the end of exercise. The changes in:12-minute walking distance
■re analysed using' the Wilcoxon Signed Rank test, as a normal
stribution of the population could not be assumed.
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Results appertaining to the study of the effect of carboxy-
haemoglobin on exercise tolerance
All patients were hypoxic at rest, breathing air (mean Pa02 =
52.0 + 3.8 mm Hg), with moderate C02 retention (mean PaC02 =
45.2+ 3.0 mm Hg) (Table 6; subjects 1-9). Each patient was
clinically stable when studied, and had not smoked for 12 hours
prior to the study. The mean initial COHb level was 3.0 + 0.9%
and rose to 12.6 + 1.0% after exposure to carbon monoxide. As
the CoHb level changed, the intial P50^ ^ value (mean 25.9 +
0.8 mm Hg) decreased significantly (P <0.001) to 24.7 + 1.2 mm Hg,
reflecting the increase in haemoglobin oxygen affinity caused by
COHb.
The 12 minute walking distances for each patient, studied
on two occasions, are shown in Table 7. Although the order
of the two walking tests, breathing air and oxygen, were reversed
on the second occasion, there was no significant difference
between the distances walked when breathing air on those two
occasions, nor the distances walked when breathing oxygen
(P^'O.IO), indicating the absence of a training effect, or
patient fatigue.
Walking distances varied a great deal between subjects
(range 168 metres - 991 metres) , but allowing each subject to
serve as his own control, changes in the distances walked while
breathing the various gas mixtures can be seen. At low COHb
levels the distance walked while breathing oxygen (mean 797 + 174
metres) was found to be greater (P < 0.20) than that covered when
breathing air (mean 767 + 178 metres). Similarly, after elevation
of CoHb levels, the average distance walked when breathing oxygen
(771 + 192 metres) was significantly greater (P<0.02) than the
average distance walked when breathing air (715 + 201 metres) (Fig 24)
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Figure 24
The 12-minute walking distances for 9 patients with chronic
bronchitis, determined when the patients were breathing air
and 02, before and after in vivo elevation of COKb levels on
2 occasions.
The distance walked when breathing air was significantly
reduced (P <0.01) after COHb levels had been increased, and
similarly, the distance walked when breathing oxygen
was reduced after elevation of COHb levels (P<0.10).
The walking distances for each patient did not correlate
with resting arterial breathing air, nor with resting or
post-exercise arterial oxygen saturation assessed by the Hewlett
Packard ear oximeter (Tables 6,7). However, there was a
significant correlation between the calculated levels of the
femoral venous oxygen tension and walking distance when
venous oxygen tension was calculated assuming an arterio-venous
oxygen content difference of 7 mls/100 ml blood (r = 0.34,
P <0.01), and also when the venous oxygen tension was calculated
assuming an arterio-venous oxygen content difference of 10 mis/
100 ml blood (r = 0.33, P < 0.01) (Figs.25 and 26).
However, as .the 12 minute walking distance of subject 9
was markedly lower than that of the other subjects, the inclusion
of this data may have weighted the relationship. Therefore,
the relationship between femoral venous oxygen tension and
walking distance was reassessed having omitted the results of
subject 9. The femoral venous oxygen tension, calculated
assuming an arterio-venous oxygen content difference of 10 mis/
100 ml blood, showed a correlation with walking distance, signifi
cant at the 10% level (r=0.25) (Fig. 27 ), but there was no
significant relationship between femoral venous oxygen tension,
calculated assuming an arterio-venous oxygen content difference
of 7 mls/100 ml blood, and walking distance (Fig. 28 ).
There was no significant change in mean resting 2,3-DPG
concentration'after elevation of COHb levels. However, at
basal COHb concentration, the mean post-exercise 2,3-DPG
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emoral venous C>2 tension, calculated assuming an arterio-venous
2 content difference of 7 ml O2/IOO ml blood, is plotted againsth® 12—minute walking distances for each patient, measured when
reathing air and O2, before and after in vivo elevation of COHb
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emoral venous 02 tension, calculated assuming an arterio-venous
2 content difference of 10 ml O2/IOO ml blood, is plotted against
—he 12-minute walking distances for each patient (excepting patient
) when breathing-air and 02, before and after in vivo elevation
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Femoral venous O2 tension, calculated assuming an arterio-venous
02 content difference of 7 ml O2/IOO ml blood, is plotted againstthe 12-minute walking distances for each patient (excepting patient
9) when breathing air and 02, before and after in vivo elevation
of COHb levels (r = 0.20, P»0.10).
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concentration was significantly lower than the mean resting
2,3-DPG concentration, but this exercise-induced change in 2,3-DPG
was not found after the COHb concentration had been raised(Table 8 ).
There was no significant change in mean resting extra¬
cellular and intracellular pH after elevation of COHb levels.
However, after exercise at low COHb levels, there was a
significant rise in mean extracellular and intracellular pH, although
this post-exercise increase did not occur after elevation of
COHb concentrations.(Table 8).
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Discussion of results appertaining to the study of the effect
of carboxyhaemoglobin on exercise tolerance
The results of this study confirm those of Leggett and
Flenley (1977), who, using 12 minute walking distances as a
measure of exercise tolerance, demonstrated the beneficial
effect of oxygen on exercise capacity in patients with chronic
bronchitis and emphysema. These authors, however, confined
their investigations to patients with low carboxyhaemoglobin
concentrations, and did not study the effect of elevated carboxy¬
haemoglobin concentrations on the exercise tolerance of patients
when breathing air or oxygen.
Vogel and Gleser (1972), Aronow and Cassidy (1975) and
! T
Seppanen (1977) found a marked reduction in exercise tolerance
in healthy subjects after elevation of carboxyhaemoglobin
levels, and Aronow, Ferlinz and Glauser (1977) extended this
observation to patients with chronic obstructive airways
disease, when exercise tolerance was assessed by bicycle
ergometer exercises.
The levels of carboxyhaemoglobin employed in our study were
greater than those used by Aronow et al (1977), but as these
higher levels corresponded to out-patient carboxyhaemoglobin
levels observed in a number of patients who were smoking, it could
not be considered excessive.
The 12 minute walking test (McGavin, Gupta and McHardy, 1976)
provides a simple measure of disability in patients with chronic
obstructive airways disease. It has been shown to provide more
reproducible results that those obtained by other respiratory
function, and exercise tolerance tests, which include measurement
of minute ventilation, heart rate, and oxygen uptake at different
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levels of exercise (Mungall and Kainsworth, 1979). However,
the same authors found that there appears to be improvement
in the performance of this test over the first two walks, but
in this study we attempted to eliminate this effect by
alternating the order of the walks breathing air and oxygen,
on the two occasions that each patient was studied, so that if
such a training effect was present, it would become apparent
as a difference in the walking distances, while breathing the
same gas mixture, on the two occasions. However, there was
no significant difference between the walking distances on the
two occasions while breathing the same gas mixtures, which
suggests that the exercise test was free from the training
effect reported by Mungall and Hainsworth (1979).
However, like all exercise tests, patient co-operation and
commitment were vital to the accuracy of the results, and for
this reason results from the very few patients who were unhappy
to continue the studies to completion were rejected. Having
taken these steps, we feel confident that the walking distances
measured in this study accurately reflect the exercise tolerance
of the patients.
The results of this study show that exercise tolerance
does improve when oxygen is administered, both at normal carboxy-
haemoglobin levels, and after inhalation of carbon monoxide to
raise carboxyhaemoglobin levels by 10%. However, arterial
oxygenation is not the major determinant of exercise tolerance,
as indicated by the absence of a correlation between arterial
oxygen saturation and 12 minute walking distance. The oxygen
supply to the working muscles is the most important determinant
of exercise capacity, and this depends upon the position and shape
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of the oxygen dissociation curve, the oxygen content of the blood
and leg blood flow. At low carboxyhaemoglobin levels, it is
probable that arterial oxygenation reflects tissue oxygen
supply, with the result that any increase in arterial oxygen
saturation is accompanied by an increase in exercise tolerance,
as shown by the patients in this study. However, elevation of
carboxyhaemoglobin concentration impairs oxygen supply to the
muscles regardless of the arterial oxygen tension or saturation,
with the result that the distance walked when breathing air was
reduced and the beneficial effects of oxygen on the 12 minute
walking distances was effectively abolished, there being no
significant change in the mean walking distance when breathing
oxygen at high carboxyhaemoglobin concentration from the mean
walking distance when breathing air at low carboxyhaemoglobin
levels.
The presence of carboxyhaemoglobin lowers the oxygen
carrying capacity of the blood, and also shifts the oxygen
dissociation curve to the left, indicating increased affinity of
haemoglobin for oxygen. This leftward shift of the
dissociation curve appears to be unopposed by any immediate
compensatory increase in 2,3-DPG or H+ concentrations, as there
=was no significant change in the concentration of either of these
haemoglobin ligands after acute elevation of carboxyhaemoglobin
concentrations.
The leftward shift of the oxygen dissociation curve is most
cronounced at the oxygen tensions present at the tissue level of
exercising muscle (Vogel and Gleser, 1972), thus in order for
exygen extraction to remain unchanged, tissue oxygen tension must
—)e lower than that present when carboxyhaemoglobin concentrations
ire low. From studies in normal subjects, Vogel and Gleser (1972)
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demonstrated that after exposure to carbon monoxide, the
lower oxygen delivery, resulting from the carbon monoxide-induced
functional anaemia, was indeed compensated by tissue oxygen
extraction to a lower venous oxygen tension, and suggested
that when carbon monoxide exposure is combined with altitude,
or disease-produced forms of hypoxia, their effect on tissue
oxygen tension, and therefore exercise tolerance, would be
additive, a suggestion supported by our results.
The relationship between the calculated femoral venous
oxygen tension and the 12-minute walking distance observed in
this study, suggests that muscle hypoxia is the limiting factor
in exercise capacity in these patients, the existing hypoxia being
aggravated by carbon monoxide inhalation from, for example,
cigarette smoke. In addition, Flenley, Brash, Clancy, Cooke,
Leitch, Middleton and Wraith (1979) suggested that the oxygen
tension of exercising muscle may be important in stimulating
hyperventilation during exercise. It is possible, therefore,
that those patients with the lowest tissue oxygen tensions
were hyperventilating maximally at an earlier stage of exercise,
and so were unable to carry on exercising for the same length of
time, due to ventilatory limitations, as those patients with a
higher tissue oxygen tension.
CHAPTER 7
Study of Christiansen, Douglas, Haldane (C.D.H.) Effect jq«
Subjects and experimental design
Blood from seven healthy men, all non-smokers, was studied
in order to assess the magnitude of the CDH effect in normal
subjects. Individual variation of the CDH effect was
investigated in one subject studied on five occasions over
a period of 20 days. Normal haematological status in these
subjects was confirmed by measurement of P50^ ^ and
2,3-DPG and haemoglobin concentration.
Blood from 14 healthy women was similarly investigated
to assess the normal CDH effect in women. Six of the women
were smokers, but all refrained from smoking on the day
of study to ensure carboxyhaemoglobin levels were low.
As initial results in some women suggested that the
CDH effect varied greatly through the menstrual cycle, the
women were divided into three groups to investigate this
phenomenon further. Group A consisted of four women (age
range 24 - 35 years, mean age 28+5 years) who were not
taking oral contraceptives. All were studied at menstruation
and as close as possible to ovulation, as judged by body
temperature. Normal haematological status was confirmed by
measurements of P50^ ^y 2,3-DPG and haemoglobin concentration.
Investigations were repeated in two of the four subjects.
Group B consisted of eight women (age range 18 - 25
years, mean age 22+3 years) who were established on a
course of oral contraception for between 12 and 48 months. All
were studied at menstruation, usually between days 3 - 5 of
the 7-day "pill-free" phase of the cycle, and again between
days 14 - 18 of the cycle. In addition to the measurements of
P50(? 4y 2,3-DPG and haemoglobin concentrations carried out
in all subjects, estimations of plasma haemoglobin, met-
haemoglobin, reduced glutathione and ferritin were also
* oral contraceptive: 30jug ethinyloestradiol, 0.15 mg D-norgestrel
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carried out in three women (by staff of the Department of
Haematology, Royal Infirmary of Edinburgh), and glycosylated
haemoglobin levels were also determined in one subject for
two consecutive months (by staff of the Department of
Clinical Chemistry, Royal Infirmary of Edinburgh). All
measurements of the CDH effect in these subjects, with
the exception of one subject, were repeated at least once.
Using blood from one subject in group B who showed marked
variation in the CDH effect through the menstrual cycle, the
CDH effect was determined simultaneously in whole blood and
also in washed red blood cells resuspended in physiological
saline containing fatty acid-free albumin and bicarbonate
ions. This procedure was carried out at menstruation and
mid-cycle for two months, to determine whether the changing
CDH effect is a property of red blood cells or plasma.
Group C consisted of two women (aged 21 and 29 years)
who were starting a course of oral contraception. Both were
studied at menstruation immediately prior to starting oral
contraception, and at mid-cycle and menstruation for the first
two months of oral contraceptive treatment. In both
subjects P50^ 2,3-DPG and haemoglobin concentrations were
determined, together with plasma haemoglobin, methaemoglobin,
reduced glutathione and ferritin. Glycosylated haemoglobin
levels were determined in one subject.
Statistical comparison of mean values between the
groups of women were carried out using the unpaired 't * test.
The CDH effect was also investigated in 10 patients
(3 post-menopausal women and 7 men) with chronic bronchitis and
emphysema, aged 54 - 70 years. All patients had severe
airways obstruction (mean FEV^ q 0.6 + 0.29 L) and were
hypoxaemic at rest (mean arterial P02 51.5 + 4.2 mm Hg) , but
were free from infection and in a stable clinical state when
studied. Although several patients smoked, they were asked
to refrain from smoking on the day of the study.
Each patient was studied twice, venous blood being
taken on each occasion for determination of the CDH effect,
P50^7 2,3-DPG and haemoglobin concentrations at a low
carboxyhaemoglobin concentration, and again after in vivo
carboxyhaemoglobin saturation had been raised by 10%.
Statistical comparisons of mean values of the CDH
effect at low carboxyhaemoglobin saturations and high
carboxyhaemoglobin saturations were carried out using the
paired 't * test, and comparison between the mean CDH effect
of normal subjects and that of the patients was carried out
using the unpaired 't' test.
105
Results appertaining to the investigation of the C.D.H. effect
For each subject, carbon dioxide dissociation curves
were constructed at haemoglobin oxygen saturations of 50 and
100%, as shown in Figure 29. From these curves, the C.D.E.
effect was obtained as the difference in carbon dioxide
content between the two curves at a carbon dioxide tension of
40 mm Hg and expressed as mmoles of carbon dioxide per litre
of whole blood. Expressed in this way, however, the C.D.H.
effect did not relate to a constant change in whole blood
oxygen content, as haemoglobin concentration varied markedly
between subjects. This was overcome by calculating the
change in oxygen content accompanying the partial reduction of
oxyhaemoglobin, and expressing the C.D.H. effect as the
change in C02 content per change in 02 content at PC02 of
40 mm Hg.
a) Results from normal male subjects
Results obtained in seven normal healthy men are shown
in Table 9 . In each subject, COIIb levels were below 3.0%
and the meanP50^ ^ and 2,3-DPG concentration were within
the normal range. The C.D.H. effect in these men (mean value
0.34 + 0.03 mMC02/mM change in 02) showed little variation
between subjects, and maintained a reasonably constant value
in one man studied on five occasions over a period of 20 days
(mean 0.32 + 0.03 mM C02/mM change in 02, range 0.29 - 0.35
mM C02/mM change in 02>.
b) Results from normal female subjects
In women, the situation proved more complex. Those
















hole blood CO2 dissociation curves at oxyhaemoglobin saturations
>f 50% and 100% in a normal male subject, showing the CDH effect
s determined in this study, and defined as the change in CO2 content
t PCO2 40 mm Hg accompanying an oxyhaemoglobin saturation change
f 50%.
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showed little variation in the C.D.H. effect between subjects,
and the mean value at menstruation (mean 0.35 + 0.07 mM C02/mM
change in 02) did not differ significantly from that at the
mid point of the menstrual cycle (0.34 + 0.05 mM C02/mM change
in 02). In vitro P50^ together with haemoglobin and 2,3-DPG
concentrations were normal, and did not alter significantly
through the menstrual cycle (Table 9 ).
c) Results from normal females taking oral contraceptives
The mean mid-cycle C.D.H. effect for women in group B,
who were established on a course of oral contraception, was
similar to that of group A (mean value 0.34 + 0.04 mM C02/mM
change in 02), but at menstruation, the C.D.H. effect in group B
(mean value 0.22 + 0.04 mM C02/mM change in 02) was
significantly lower (P <0.001) than that in group A (Fig. 30 ).
2,3-DPG and haemoglobin concentrations were within the normal
range and did not alter significantly during the menstrual cycle,
but in vitro P50^ ^ was significantly higher (P <0.0 5) at
menstruation (mean value 27.4 + 1.8 mm Hg) than at mid-cycle
(mean 26.8 + 1.6 mm Hg) in these women (Table 9 ).
The concentrations of reduced glutathione, methaemoglobin,
plasma haemoglobin and ferritin, determined in three women from
group B, did not alter significantly during the menstrual cycle.
In addition, the concentration of glycosylated haemoglobin
determined in one woman at menstruation and mid cycle over
two consecutive months, did not vary, although the C.D.H. effect in
this subject did alter through the cycle (Table 10 ).
The simultaneous determination of the C.D.H. effect using
whole blood and resuspended red cells from one subject taking
an oral contraceptive, showed no difference between the C.D.H.
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The CDH effect determined at menstruation and mid-menstrual
cycle in women who were not taking oral contraceptives (ip) and
women taking the combined oestrogen-progesterone contraceptive
pill m.
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effect determined in whole blood and that determined using
resuspended red cells. In this subject the C.D.II. effect,
determined on two separate occasions at menstruation was 0.23 and
0.29 mM COg/mM change in 02 in whole blood, and 0.22 and
0.27 mM C02/mM change in 02 in resuspended red cells. At mid
cycle, the C.D.H. effect determined in whole blood was 0.39 and
0.40 mM C02/mM change in 02, and in resuspended red cells was
0.40 and 0.42 mM C02/mM change in 02-
d) Results from normal females beginning a course of oral
contraceptives
The C.D.H. effect, together with P50^ ^ and concentrations
of 2,3-DPG and haemoglobin determined in two women immediately
before and for two months after beginning a course of oral
contraception are shown in Table 11 . Subject 18 had a normal
C.D.H. effect immediately before and 14 days after beginning
oral contraception, but after one month, the C.D.H. effect was
markedly lower than the pre-treatment value. At mid cycle during
the second month, the C.D.H. effect returned to normal, but decreased
again at menstruation at the end of the second month (Fig.31 ).
In subject 17, the C.D.H. effect determined immediately prior
to beginning the course of oral contraception was slightly
higher than normal, but fell to within the normal range after
14 days of oral contraception. There was no reduction in the C.D.H.
effect at menstruation in this subject during the first month,
and it remained essentially unchanged at mid cycle in the
second month. However, at the end of the second month a reduction
in the C.D.H. effect was observed (Fig.31 ).
The C.D.H. effect in both these subjects bore no relationship
to levels of reduced glutathione, methaemoglobin, plasma
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Figure 31
The CDH effect determined in two women immediately before,tat
two week intervals, for two months after beginning a course of
oral contraception, showing the development of cyclical variation
in the CDH effect.
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levels, measured in subject 17, did not correlate with the
C.D.H. effect (Table 12 ).
e) Results from patients with chronic bronchitis
In ten patients with chronic bronchitis and emphysema,
all of whom were hypoxaemic when breathing air at rest (Table 4 ),
the mean C.D.H. effect measured on two occasions when carboxy-
haemoglobin levels were low was 0.30 t 0.07 "mM CC>2/mM change
in O2, a value which did not differ significantly from that
in normal subjects. However the patients showed a greater
range of values for the C.D.H. effect than the normal subjects
(range 0.18 - 0.50 mM COg/mM change in O2) (Table 9 ), and
with the exception of only one patient ( 3 ), the values
remained reasonably constant over the two measurements.
After in vivo elevation of carboxyhaemoglobin levels,
there was no significant change in the mean C.D.H. effect
(0.33 * 0.08 mM C02/mM change in O2) from that observed at low
carboxyhaemoglobin levels, but again the values were scattered
over a wide range (range 0.21 - 0.49 mM COg/mM change in O2).
In addition the patients demonstrated a higher carbon
dioxide combining power (defined as whole blood carbon dioxide
content at PCO2 of 40 mm Hg, when fully saturated with oxygen)
than the normal subjects, resulting from the prevailing high
PCO2 in these patients.
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Discussion of results appertaining to the investigation of
the CDH effect
The CDH effect, as determined in this study, is the
result of two mechanisms: a) the change in pH accompanying
oxygenation, which alters the concentration of bicarbonate,
and b) the oxylabile binding of carbon dioxide to haemoglobin
as carbamate. At pH 7.40 and PC02 40 mm Hg, the change in
bicarbonate concentration on oxygenation accounts for 60% of
the CDH effect, with the change in carbamate concentration account¬
ing for only 40% of the CDH effect (Klocke, 1973).
In the construction of CC>2 dissociation curves, pH was
allowed to change with PC02, mimicking a state of acute respiratory
acid base imbalance (in vitro). The results of Klocke (1973)
suggest that under these conditions, the CDH effect remains
reasonably constant over the PC02/pH range used in our
study, although the relative contributions of changes in carbamate
and bicarbonate concentrations to the CDH effect will vary with
PC02 and pH. As the pH increases, the formation of carbamate
in reduced haemoglobin increases, with the result that on
oxygenation at a pH of 7.6, the change in carbamate concentration
is greater than that occurring at a lower pH. This increased
dissociation of carbamate at the higher pH value allows greater
buffering of hydrogen ions which reduces the change in bicarbonate
concentration accompanying oxygenation, thereby reducing its
relative contribution to the CDH effect. At lower pH values
the reverse is true, with the change in bicarbonate concentration
contributing most to the CDH effect, but the overall change
in carbon dioxide content on oxygenation remains reasonably
constant.
The CDH effect determined in this study, and expressed
as the change in carbon dioxide content per change in oxygen
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content, could not be compared directly with estimates
of the CDH effect made by previous authors, for, despite
being expressed in the same way, previous determinations involved
the complete reduction of oxyhaemoglobin, whereas in this study,
oxyhaemoglobin was reduced by only 50%. In order to compare
our results with those of others, it was necessary to demonstrate
that the change in whole blood carbon dioxide content
accompanying 50% reduction of oxyhaemoglobin is half of that
accompanying complete reduction. Ferguson (1936) and
Baumann, Bauer and Haller (1975) suggest that at constant
PC02 the carbamino binding of carbon dioxide to haemoglobin is
linearly related to oxygen saturation, but Garby, Robert and
Zaar (1972) suggest this is not so. However, none of these
authors determined the relationship pertinent to this
discussion, that is, the relationship between whole blood carbon
dioxide content (which includes bicarbonate and carbamate)
and oxygen saturation. We investigated this relationship by
equilibrating aliquots of whole blood with gas mixtures
containing 6% C02 and various concentrations of 02, designed to
produce a range of oxyhaemoglobin saturations. The pH of the
samples was allowed to change with saturation in order to mimic
the conditions of the main experiments. The results shown in
Fig.32 indicate that the relationship between carbon dioxide
content and oxygen saturation is linear, and also, that, for
comparison purposes, the change in carbon dioxide content
determined as oxyhaemoglobin is reduced to 50%, closely
approximates half of that occurring when oxyhaemoglobin is fully
reduced.' Thus, when expressed per change in oxygen content, the
CDH effect determined in this study is equivalent to that,
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The relationship between whole blood CO2 content and O2
saturation at PCO2 50 mm Hg, indicating that CO2 content
varies linearly with O2 saturation.
Ill
expressed in a similar way, in other studies.
The normal CDH effect
The mean CDH effect determined in normal men (0.34 + 0.03
mM C02/mM change in C^) and normal women who were not taking
oral contraception (Group A) (0.34 + 0.05 mM C02/mM change in
02 at mid menstrual cycle and 0.35 + 0.07 mM C02/mM change in
O2 at menstruation) compares favourably with results obtained
by others. Christiansen, Douglas and Haldane (1914), using
whole blood, obtained results which, when expressed as above,
gave a value of 0.34 mM CC^/mM change in C^, and Ferguson (1936)
found the CDH effect in haemoglobin solutions was 0.35mM CO2/
mM change in 02.
The CDH effect in patients with chronic bronchitis
The CDH effect in patients with chronic obstructive airways
disease (mean 0.30 + 0.07 mM C02/mM change in 02) is
comparable with that in the normal subjects, and is similar to
that determined by Lenfant, Ways, Aucutt and Cruz (1969) in a
similar group of patients with chronic airways obstruction.
Using the carbon dioxide dissociation curves determined in
patients with chronic bronchitis, the rise in PC0„ accompanying
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oxygenation at a constant whole blood CO2 content can be
estimated. From Fig.29 it can be seen that an increase in oxygen
saturation from 50% to 100% would increase the PCC^ by
6-8 mm Hg, if CO2 content remained constant. However, it has
been reported that in vivo, the slope of C02 dissociation curves
is less steep than it appears in vitro due to the redistribution
of bicarbonate between intra- and extravascular spaces in vivo
(Roos and Thomas, 1967). This would suggest a greater rise in
PCOg accompanies oxygenation at a constant C09 content in vivo.
However, the extravascular fluid in the pulmonary circulation is
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negligible in comparison to the amount of circulating blood,
so that the in vitro C02 dissociation curve could be considered
to be the in vivo one, and the rise in PC02 on oxygenation in the lungs
could be predicted from the in vitro curves.
The CDH effect, together with the reduction in ventilation
on removal of the hypoxic stimulus by oxygen administration,
may lead to hypercapnia in some patients. Data from Flenley,
Franklin and Millar (1970) indicated an average rise in PC02
of 16 mm Hg as oxygen saturation increased from 86% to 100%. As
C02 content is linearly related to oxygen saturation, it can be
assumed that the CDH effect accompanying this rise in oxygen
saturation of 14%,will be 28% of the CDH effect accompanying a
rise in oxygen saturation of 50%, which has been determined in
this study. Thus, as the oxygen saturation is raised from
86% to 100%, the theoretical rise in PC02 resulting from the CDH
effect would be 2 mm Hg, accounting for only 12.5% of the
16 mm Hg rise in PC02 observed in these patients by Flenley
et al (1970), the remainder presumably resulting from the removal
of the hypoxic ventilatory drive.
In addition, our results indicate that an increase in
carboxyhaemoglobin concentration, in vivo, does not alter
the CDH effect accompanying a constant change in oxygen saturation,
if oxygen saturation is expressed as a percentage of total
haemoglobin (i.e. S02T), which suggests that the rise in PC02
accompanying oxygenation will be constant whether the patient
is a smoker or a non-smoker.
The CDH effect in women taking oral contraceptives (Groups B & C)
Variation in the magnitude of the CDH effect throughout
the menstrual cycle develops quickly following the start of oral
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contraception, the characteristic decrease in the magnitude
of the CDH effect at menstruation appearing within the first
two months of treatment.
Because we were able to demonstrate variation of the CDH
effect in both whole blood and washed red blood cells, it
appears that this cyclical variation is produced by a change in
the properties of the red cells, as distinct from a change in
the properties of the plasma. It is unlikely that oestrogens and
progestagens are directly responsible for these changes within
the red cells, for changes in the concentration of these substances
through the menstrual cycle in women who are taking oral
contraceptives are negligible when compared with the changes which
occur in normal ovulating women, and even during the early
follicular phase of the menstrual cycle, levels of oestradiol
in normal women are three times those in oral contraceptive users
(Kjeld, Puah and Joplin, 1976). Furthermore, it is unlikely that
sex steroids can penetrate the red cell membrane due to their large
molecular dimensions. It appears more reasonable to suggest
that chronic low levels of exogenous oestrogens and progestagens
induce secondary changes, and it is these changes which influence
the red cell. However, these changes within the red cell have not
been identified despite a number of pertinent investigations:-
a) the consistency of 2,3-DPG and glycosylated haemoglobin
concentrations throughout the menstrual cycle suggests that
neither of these substances were responsible for the change in the
CDH effect, despite having the ability, in theory, to block
the formation of carbamate compounds in the haemoglobin molecule,
as both 2,3-DPG, and the hexose moiety in glycosylated haemoglobin
bind to the same ^-amino groups as carbon dioxide.
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b) levels of plasma haemoglobin, reduced glutathione,
methaemoglobin and ferritin were monitored in a vain attempt
to relate changes in the CDH effect to any changes in the red
cell membrane integrity, the redox state of the haemoglobin
iron, or the turnover rate of haemoglobin, but again, no
relationship emerged.
c) the change in base excess which accompanies reduction
of oxyhaemoglobin did not differ throughout the menstrual cycle,
indicating that there was no change in the magnitude of the
pH-shift accompanying the reduction of oxyhaemoglobin, and this
could not therefore have influenced the pH-dependent formation
of carbamate.
Several authors have demonstrated an increase in ventilation
after administration of progesterone (Hasselbalch, Gammeltoft,
1915; Bohelmann, Rother, 1924; Lyons, 1969). Although the
mechanism of this action is not certain, the hyperventilation
produced, leads to a respiratory alkalosis, which is compensated
by a fall in bicarbonate concentration. At menstruation, 3-4
days after oral contraceptive administration has stopped,
ventilation is restored to normal, and bicarbonate concentration
rises again due to renal reabsorption. The in vitro consequence
of these changes is that at mid cycle, the blood will be more
acidotic when equilibrated with a given PC02 than it will be
at menstruation. However, as shown by the work of Klocke (1973)
(Fig. 7 ), changes in pH over the range 7.3 - 7.6 have little
effect on the overall CDH effect, and it is unlikely that this
acid base imbalance could account for the large changes in the
CDH effect observed in this study.
Thus, we have not been able to explain the mechanism of
the change in the CDH effect which occurs at the time of
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menstruation in women taking combined oestrogen/progesterone
oral contraceptives.
Comparison of measured and calculated values for whole blood
C02 content
From measurements of whole blood CC^ content made using the
I.R.G.A., we were able to assess the accuracy of the formula
of Visser (1960) for predicting whole blood CC^ content, and
the change in C02 content accompanying the oxygenation of
haemoglobin. Using PC02 and pH values obtained during the
construction of CO2 dissociation curves for both the normal
subjects and the patients with chronic airways obstruction,
plasma C02 content was estimated by the Henderson-Hasselbalch
equation, assuming pK'of 6.1:-
[ C02 ] = 0.03 PC02 (1 + 10 pH -6-1)
and this, together with values for haemoglobin concentration,
oxygen saturation, and capacity were then substituted into
Visser's equation:-
Blood C02 content = Plasma CO., content (1 - °"°^ * 74 - pH)>
■By repeating these calculations for each subject, using data at
-two levels of oxygen saturation, the change in CO2 content
-accompanying oxygenation could be calculated, although this
-value was not necessarily the CDH effect as defined in this study,
■as CO2 tensions at the two levels of oxygen saturation were not
-always equal.
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The whole blood C02 contents (expressed as mmol/1)
measured by the IRGA and calculated using the formula of Visser
are compared in Fig.33. The data from the normal subjects
deviates slightly from the line of identity, the calculated
values being lower than the measured values over the range
17.5 - 22.5 mmol/1. Data from the patients, however, shows
greater deviation from the line of identity over the range
18.5 - 26.0 mmol/1, with the calculated C02 content being
significantly lower than the measured CO^ content (P <0.001).
When the formula was used to estimate the change in C09
content accompanying a change in oxygen saturation, a comparison
with the measured values showed that the data was evenly
distributed about the line of identity, but individual results
show wide variation between the calculated and measured
values (Fig.34 )•
It appears, therefore, that the formula of Visser is
adequate to provide an approximate estimation of whole blood
C02 content in normal subjects only most similar calculations
in patients with chronic bronchitis being underestimated.
Furthermore, the wide individual variations observed between
the calculated and measured values for changes in C02 content
accompanying changes in oxygen saturation, in both normal
subjects and patients with chronic bronchitis, suggest that the
formula would be unsatisfactory for estimating the CDH effect,
although the least squares regression line for the data lies
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Figure 33
A comparison of calculated whole blood CO2 content (calculated
using the formula of Visser (I960)) with that measured
using the I.R.G.A. in normal subjects (o) (r = 0.85,
P<0.001), and patients with chronic bronchitis (•) (r = 0.72,
P<0.001).
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A comparison of the calculated change in whole blood CO2 content
(calculated using the formula of Visser (I960)) with the
measured change occurring as oxygenated haemoglobin is reduced to
50% oxygen saturation in normal healthy subjects (o) and patients




In final answer to the questions posed in Chapter II
therefore:-
1. Long term oxygen therapy does not alter the position
or shape of the oxygen dissociation curve of the blood, nor
does it affect the mean corpuscular haemoglobin concentration,
or arterial blood gas and pH values obtained with the patient
breathing air. However, haemoglobin concentration, packed
cell volume and 2,3-DPG concentration decreased in those patients
receiving oxygen therapy after only one year of treatment,
these lower levels being maintained for the remainder of the
study. No corresponding changes were observed in the control
group patients.
2. The degree of secondary polycythaemia associated with
chronic bronchitis is related to the smoking habits of the
patients, and the correlation between renal medulla POg and red
cell mass (r = -0.51, P<0.001) suggests that hypoxaemia
in this region of the kidney may activate the erythropoietic
response to hypoxia.
3. Exercise tolerance is significantly impaired following
acute elevation of carboxyhaemoglobin concentration in patients
with chronic bronchitis and emphysema. The exercise tolerance in
such patients is related to tissue oxygenation, and is
increased when the oxygen supply to the working muscles is
increased. However, as carbon monoxide displaces oxygen
from combination with haemoglobin, the benefit of oxygen
administration to patients with elevated carboxyhaemoglobin
concentrations is limited by the lower oxygen carrying capacity
of the blood, with the result that exercise tolerance in such
patients is lower than that in patients with normal carboxy¬
haemoglobin concentrations, despite comparable arterial POg levels.
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4. The formula of Visser (1960) appears suitable to
provide an approximate indication of whole blood CC>2 content in
normal subjects, but it is unsuitable for the calculation of
CO2 content in patients with chronic bronchitis, most of the
calculated values being lower than the measured values. When
the formula is used to assess the change in C02 content
accompanying a change in 02 content, marked individual variations
between the measured and calculated values suggest that the
formula is unsuitable for the estimation of the CDH effect.
5. The magnitude of the CDH effect determined in patients
with chronic bronchitis was similar to that determined in normal
subjects, and calculations based on these measurements suggest
that only about 12% of the overall rise in PCC>2, observed
in some patients when arterial oxygenation is increased, is a
result of the CDH effect, the remainder resulting from the
removal of the hypoxic ventilatory drive.
6. The CDH effect in patients with chronic bronchitis is
not altered by elevation of carboxyhaemoglobin concentration in
vivo, indicating that cigarette smoking in such patients would
have no effect on the CDH effect,
7. In normal women the CDH effect remains constant throughout
the menstrual cycle. In women taking the combined oestrogen-
progesterone contraceptive pill, the CDH effect mid-way through
the cycle is comparable with that in normal women, but at
menstruation, the magnitude of the CDH effect falls, the mean
value at menstruation being only 65% of the mean mid-cycle value.
8. The biochemical mechanisms responsible for the
variation in the CDH effect through the menstrual cycle in women
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Arterial blood gas and pH data, F.E.V.1>0, R.C.M. and P.A.P.
















1 F 61 58 57 7.39 0.20 29 35
2 M 63 60 46 7.41 1 .35 25 25
3 F 62 53 57 7.40 0 .45 32 41
4 M 58 53 54 7.39 0 .50 31 32
5 F 55 47 64 7.33 0.75 48 28
6 F 55 57 50 7.39 0 .70 33 18
7 M 68 44 56 7.32 0.45 43 40
8 F 58 47 52 7.43 0.45 28 43
9 M 53 55 55 7.39 0 .55 35 47
10 M 63 53 53 7.37 0 .65 33 36
11 M 54 50 67 7.39 0.70 42 54
12 M 42 54 49 7.41 0 .41 43 60


















Arterial blood gas and pH data, F.E.V.1>0, R.C.M. and P.A.P.
















14 M 65 48 57 7.38 0 .50 41 36
15 M 63 58 57 7.39 0 .70 44 33
16 F 67 47 63 7.38 0 .51 48 23
17 M 59 53 50 7.36 0 .61 35 33
18 M 45 60 59 7 . 39 0.55 38 27
19 F 55 57 57 7.35 0 .55 44 30
20 M 63 52 57 7 . 39 0 .95 37 31
21 F 67 47 52 7.39 0.20 25 39
22 M 66 48 62 7.33 0 .35 48 52
23 F 59 57 51 7.39 0 .65 26 33
24 M 63 59 49 7.41 0 .95 38 24
25 F 55 59 55 7.40 0.50 40 46


















Mean values t. 1 standard deviation for the control group patients, initially, and after 1, 2 and 3 years of the study,
and for the patients receiving oxygen therapy, initially and after 1 year, 2 years and 3 years of the study.
Significant differences between the two groups are indicated.
Initial Assessment 1 Year Assessment 2 Year Assessment 3 Year Assessment
Control 02 Therapy Control 02 Therapy Control 02 Therapy Control 02 Therapy
Patients Patients Patients Patients Patients Patients Patients Patients
Pa02 mean 52.9 53.8 57.0 57.0 53.0 46 .6 50.0 46.0
(mm Hg) S.D. 4.8 5.1 10.4 6.4 11.8 7.6 1.1 10.0
n 13 13 10 11 5 7 2 7
PaC02 mean 55. 1 55.8 51 .5 55.0 54 .0 58.0 59.0 55.5
(mm Hg) S.D. 5.7 4.3 5.0 6.5 3.7 7.7 4.2 6.9
n 13 13 10 11 5 7 2 7
Blood pH mean 7. 39 7.38 7 . 39 7.39 7.36 7.36 7.33 7.38
S.D. 0.03 0.02 0.03 0 .04 0 .02 0.06 0.02 0 .03
n 13 13 10 11 5 7 2 7
Red cell pH mean 7.17 7 .17 7 .13 7.13 7.14 7.12 7.05 7.13
S.D. 0.05 0.03 0.09 0.11 0 .06 0 .09 0.02 0 .04
n 12 12 9 10 4 7 2 6
P.C.V. mean 50.8 54.0 48.0 46.5 52.0 45.0 57.0 44 .0
(ml/dl) S.D. 3.9 7.3 7.2 8.5 5.2 4.8 1.0 5.3
n 13 13 10 11 5 7 2 7
<— P<0 . 05 > < P<0 . 02 *■
Hb mean 15.6 16.1 15.1 14 .1 16 .0 13.6 17.4 13.1
(g/dl) S.D. 1.1 1.8 2.4 2.0 1.9 1.4 0.4 1.6
n 13 13 10 11 5 7 2 7
«— P<0 . 05 #■ < P<0 . 0 1
M.C.H.C. mean 30.7 30.3 31.1 30.6 30.8 30.4 30 .5 29.8
(g/dl) S.D. 1.1 2.0 1.3 1.9 1 .29 0.8 1.1 1.4
n 13 13 10 11 5 7 2 7
P50(7.4) mean 27.3 26.8 27.3 27.9 27.2 26 .8 30.1 26.3
(mm Hg) S.D. 1.7 1.0 1. 3 1.3 1.5 1.2 0.8 2.1
n 13 13 10 11 5 7 2 7
/ P o A R V\ r U . \j o 7
2,3-DPG mean 16.53 15.53 14.86 14 .50 15.27 13.43 17.00 14.78
(jjmole/gHb) S.D. 2.59 1 .74 1.82 2.58 4.32 2.21 3.30 3.47
n 13 13 10 11 5 7 2 7
Hills 'n' mean 2.68 2.67 2.86 2.91 3.00 2.84 2.72 2.84
S.D. 0.31 0.15 0.32 0.32 0.34 0.27 0 .09 0.48
n 13 13 10 11 5 7 2 7
Table 3
Mean values * 1 standard deviation for the 7 oxygen therapy patients who survived for 3 years
of the study, and the 5 control group patients who survived for 2 years of the study.
















































































































































































Initial 1 year 2 year
Assessment Assessment Assessment
55.0 59.8 53.0
2.2 9 .1 11.8
54.0 52.4 54 .0
2.6 4.2 3.7
7.39 7.40 7.36
0.01 0 .04 0 .02
7.16 7.16 7 .14
0.04 0.11 0 .05
(n=4 ) (n=4) (n=4)
50.0 48.7 52.0
2.8 6.4 5.2
15.4 15.4 16 .0
1.0 2.3 2.0




< P<0 . 02 >
15.53 14.78 15.27
1 .25 1 .30 4 .32
2.63 2.74 3.00
0.41 0 .42 0.34
Table 4
Mean age, arterial blood gases and pH, and F.E.V1-0 (t 1 S.D.)












Smokers 30 59.2 ± 5.8 51.9 ± 5.4 53.1 + 6.2 7.38 + 0.04 0.60 t 0.20
Non-smokers 17 62.7 ± 6.2 54.0 t 3.9 50.1 t 8.3 7.39 t 0.04 0.60 t 0.20
All patients 47 61.0 ± 6.1 53.0 ± 4.6 51.6 ± 6.9 7.39 ± 0.04 0.60 ± 0.20
Table 5 _
Arterial blood gas tensions, pH, oxygen and carboxyhaemoglobin saturations,
red cell mass, and calulated renal venous oxygen tensions in all subjects.
Subj ects Mean COHb Sa02 Sa02A Sa02T PV02 PV02 R.C.M.
at 0% at mean at mean assuming assuming
(%)
COHb COHb level COHb level (AA-V>2ml/fc) (AA-V )=5ml/dl
(%) (%) (%) (mm Hg) (mm Hg) ml /kg
SMOKERS
1 4.5 78.0 78.0 74 . 5 37 .5 30.4 37
2 3.0 86.5 86.3 83.7 41.4 31.0 32
3 8.0 79.5 79.9 73.5 35.4 27.1 48
4 9.0 85.0 85.6 77.9 40.5 29.6 48
5 4.2 83.5 85.3 81.7 38.1 30.0 35
6 14.2 80 . 5 89.7 77.0 30 .8 26.6 47
7 6.9 86.0 83.3 77.6 36 .8 28.7 44
8 10.5 79.5 82.5 73.8 36 .0 28.0 30
9 5.4 90.0 88.5 83.7 37.5 32.4 41
10 12.0 86.0 85.5 75.2 37.0 25.6 57
11 4.5 82.5 81 .3 77.6 36.5 27.6 52.5
12 10.0 90.0 91 .6 82.4 45.2 34 . 5 55
13 6.6 89 .5 94.0 87 .8 42.5 30.3 42
14 3.5 82.5 81 .3 78.5 38.6 30.5 41
15 8.0 79.5 79.5 73.1 33.7 23.7 51
16 8.0 88.5 87.7 80.7 41.7 31.2 44
17 6 .1 85.5 85.9 80.7 40 .6 31.1 35
18 6.6 90.5 92.4 86.3 43.1 31.2 38
19 4.6 80 .5 81.3 77.6 36 .7 28.6 43
20 5.1 85.8 82.5 78.3 41.9 32.7 43
21 12.5 86 .5 97.3 85.1 42.2 34.7 35
22 9.0 90.0 94.6 86.1 41.9 31.6 36
23 7.1 90.0 93.0 86.4 42 .1 33.6 32
24 6.8 89.0 97.2 90.6 43.6 33.5 33
25 5.1 89.5 87.0 82.6 44 .8 33.4 36
26 10.0 84.0 84.5 76.1 39 .0 29.4 41
27 11.0 65.0 74.0 65.9 28.2 22.2 59
28 3.3 83.5 82 .0 79.3 41.0 32.7 43
29 12.0 91.0 99.0 88.0 44.8 35.0 38
30 8.9 86.5 87.6 79.8 39.7 29.2 54
Mean 7.5 84.8 86 .6 80.1 39.3 30.2 42.4
S.D. 3.0 5.4 6.2 5.4 4.0 3.0 8.0
n 30 30 30 30 30 30 30
NON-SMOKERS
31 2.5 86.0 88.5 86 . 3 39 . 8 29.3 29
32 2.8 82.0 78.5 76.3 40.0 30. 3 28
33 4.2 86.5 86 .5 82.9 42.9 34.8 29
34 3.3 85.0 79.5 76 .9 47.4 37.0 28
35 1.4 90.0 89.0 87.8 43.5 31.7 23.5
36 2.2 85.0 85.0 83.1 39.4 30.2 25
37 2.4 90.0 93.0 90.8 39.6 30.9 27
38 2.1 85.0 85.0 83.2 37.8 28.1 26
39 3.8 82.5 83.0 80.0 41.4 31.8 31
40 3.0 90.0 90 .0 87.3 44 .5 34.1 32.5
41 1.1 88.0 84.5 83.6 44.9 34.0 31
42 0.7 90.0 90.0 89.4 41.5 31.9 25
43 3.5 91.0 89.5 86.4 49.5 39.1 31
44 2.8 88.0 88.0 85.5 44.6 35.7 42
45 4.2 83.0 83.0 79.5 38.6 30.9 31
46 3.0 92.0 89 .0 86.3 51.0 39.0 29
47 3.2 86.0 83.5 80.8 44.6 35.6 29
Mean 2.7 87.0 86.2 83.9 43.0 33.2 29.2
S.D. 1.0 3.1 3.9 4.2 3.8 3.2 4.1
n 17 ; 17 17 I 17 17 17 17
Table 6
Arterial blood gas tension, pH and F.E.V1>0 determined on two
occasions in those patients participating in the investigation
of the effect of COHb on exercise tolerance (patients 1-9)
and also the investigation of the C.D.H. effect




















































































































































The 12-minute walking distance, post exercise arterial 02 saturation of total haemoglobin (SO?T),
and calculated femoral venous assuming arterio-venous 0^ content differences of 7 and 10mls/l00mls blood, on two
separate occasions in nine patients with chronic bronchitis and emphysema, v/hile breathing air and
before and after in vivo elevation of carboxyhaemoglobin levels.
Subject COHb POST-EXERCISE CALCULATED FEMORAL CALCULATED FEMORAL 12—MINUTE WALKING
do) ARTERIAL 0 SATURATION VENOUS P0„ VENOUS P0„ DISTANCE
(S0oT) (A(A-V) CO0 = 7mls/l00ml) CA(A-V)CO2 = 10ml s/100ml) (METRES)(%'1 (mmHg) (mmHg)
BREATHING BREATHING BREATHING BREATHING BREATHING BREATHING BREATHING BREATHING
AIR °2 AIR °2 AIR °2 AIR °2
1 2.8 78 85 25.2 28.1 19.0 21.5 924 961
13.0 - - - - - - 789 819
3.6 76 85 22.1 25.5 15.9 19.5 737 991
14.5 78 84 19.1 21.4 12.2 14.7 672 922
2 1.8 77 92 24.4 30.8 18.1 23.7 804 740
12.2 87 90 24.2 25.5 17.6 18.5 747 864
2.9 81 94 24.6 30.4 19.1 24.0 829 877
13.4 90 95 21.9 24.0 17.3 19.1 819 861
3 4.4 74 88 25.5 31.7 20.4 25.8 875 890
13.8 - - - - - - 778 888
1.9 74 88 24.4 30.6 19.1 25.0 795 859
11.7 66 88 16.9 20.3 9.6 19.6 721 819
4 2.6 — — — — — — 919 910
12.8 — 85 - 27.8 - 20.8 933 977
4.0 80 88 27.8 31.3 22.9 26.0 944 963
14.0 - 85 - 24.6 - 19.1 924 859
5 3.4 76 90 28.3 35.5 29.7 30.4 819 911
11.8 71 80 23.9 28.2 19.0 23.0 839 903
2.8 75 84 30.5 35.4 26.0 29.9 756 743
10.5 81 87 29.9 33.6 24.1 27.0 672 756
6 1.6 80 86 24,9 27.3 18*5 20.9 776 720
13.2 69 92 14-7 24.8 0 17.2 726 798
2.9 83 93 24.8 33.1 14.9 20.7 672 756
12.5 85 92 21.7 26.1 13.8 17.1 672 714
7 2.6 76 90 23.8 29.6 18.2 23.4 693 798
12.3 79 86 17.7 21.2 11.7 14.1 756 789
2.0 81 92 25.3 29.9 19.0 23.1 756 803
11.0 85 86 21.8 21.8 14.6 14.7 693 756
8 2.9 82 90 28.3 32 22.6 25.8 882 777
12.2 86 90 28.0 29.6 22.6 24.8 873 756
2.6 65 85 20.8 27.9 13.8 21.6 962 898
11.6 76 90 18.1 25.0 10.7 17.5 840 840
9 4.2 80 89 23.2 26.8 17-8 21.1 336 420
13.7 72 91 14.1 23.0 7.5 15.8 252 336
4.3 81 91 21.9 26.1 15.4 19.0 336 336
11.8 77 90 15.5 22.2 0 14.0 168 222
MEAN 3.0 77-2 88.7 25.4 30.6 19.8 24.1 767.5 797.4
S.D. 0.9 4.5 3.2 2.5 2.8 4.1 3.2 177.9 174.2
MEAN 12.6 79-4 87-9 21.5 25.2 15.7 19.1 715.2 771.0
S.D.
—
1.0 7-7 3.9 4.5 3.6 4.8 3.8 201.5 191.9
XaJaJLa a
Mean £50(7 4)> 2,3-DPG concentration, and plasma and red cell pHdetermined'on two occasions in 9 patients with chronic bronchitis
before and after in vivo elevation of COHb concentration.
COHb<4.4% COHb>10.5%
Mean £50(7.4) (mm Hg) 25.9 24.7
1 S.D. 0.8 1.2
Mean 2,3-DPG Oumoles/gHb) At rest 14.91 14.75
1 S.D. 1.70 1.50
Post exercise 14.26 14.96
1 S.D. 1.90 1 .80
Mean Plasma pH (venous) At rest 7.30 7 .32
1 S.D. 0 .04 0.04
Post exercise 7.33 7 . 32
1 S.D. 0.03 0.03
Mean red cell pH (venous) At rest 7.05 7 .06
1 S.D. 0.08 0.07
Post exercise 7.07 7 .07
1 S.D. 0.08 0 .07
Table a
Mean C.D.H. effect, 2,3-DPG concentration, P50(74), haemoglobin
concentration and carboxyhaemoglobin saturation in normal men and women,
and patients with chronic bronchitis and emphysema.
Subjects C.D.H. Effect 2 , 3-DPG P5 0( 7.4) Hb Conc^. COHb
(mM CO?/mM 09) Oumole/g Hb) (mm Hg) (g/dl) (%)
Normal Women
Group A
Mid menstrual cycle . 0.34 15.04 28.0 13.5 2.1
S.D. 0.05 1.39 1.5 0.5 1.1
n 8 8 8 8 8
Menstruation 0.35 14.92 27.9 13.3 1.8
S.D. 0.07 0.96 1.3 0.4 1.0
n 8 8 8 8 8
Group B
Mid menstrual cycle 0.34 15.11 26.8 13.8 1.7
S.D. 0.04 3.22 1.6 0.8 0.9
n 19 19 19 19 19
Menstruation 0.22 15.03 27.4 14.1 1.9
S.D. 0.04 1.82 1.8 0.9 1.0
n 19 19 19 19 19
Normal Men
Mean 0.34 13.57 28.1 15.3 2.0
S.D. 0.03 1.10 1.8 1.2 0.8
n 7 7 7 7 7
Chronic Bronchitics
Mean 0.30 14.90 25.8 15.5 3.2
S.D. 0.07 1.54 0.8 2.4 1.2
n 20 20 20 20 20
Mean 0.33 14.93 24.5 14.9 12.6
S.D. 0.08 1.47 1.3 2.3 1.1
n 20 20 20 20 20
Table 1Q
C.D.H. effect, reduced glutathione, ferritin, methaemoglobin,
plasma haemoglobin and glycosylated haemoglobin levels in
three normal women established on a course of oral contraceptives.


















9 Mid 0.39 677.0 42 1.0 0.05 -
Menstruation 0.29 - 32 - - -
14 Mid 0.30 1058.0 24 3.4 0.2 7.4
Menstruation 0.22 1228.5 9 0.8 0.2 7.8
Mid 0.29 1082.0 17 2.6 0.2 7.2
Menstruation 0.25 1089.0 29 1.2 1.2 7.6
16 Mid 0.42 866 .5 23 1.0 0.07 -
Menstruation 0.23 795.0 133 1.8 0.01 -
Mid 0.39 716.0 44 2.1 0.04 -
Menstruation 0.23 1007.0 172 1.2 0.03 -
Tahle 11
CDH effect, haemoglobin concentration, 2,3- DPG concentration, P50(7.4) and carboxyhaemoglobin
concentration in normal women immediately prior to beginning a course of oral contraceptives,
and during the first two months of oral contraceptive treatment.








17 Menstruation 0.46 13.2 2.0 15.00 26.1
«—
Mid 0.33 14.3 1.5 16.01 26.0
Menstruation 0.37 12.7 1.5 16.77 26.8
Mid 0.37 12.5 2.2 14.80 23.4
Menstruation 0.28 13.7 2.4 15.04 27.8
18 Menstruation 0.37 13.0 1.8 15.15 27.7
Mid 0.33 12.6 2.2 14.52 26 .8
Menstruation 0 .26 12.9 2.2 14.96 26.4
Mid 0.38 12.1 1.8 14.00 26.6










C.D.H. effect, reduced glutathione, ferritin, methaemoglobin,
plasma haemoglobin and glycosylated haemoglobin levels in


















17 Menstruation 0.37 1159.0 83 2.0 0.08 7.5
Mid 0.33 1070.0 13 1.0 0.08 7.8
Menstruation 0.26 1054.0 10 5.6 0.21 7.7
Mid 0.38 994.0 35 1.4 0.09 7.9
Menstruation 0.29 987.0 16 1.0 0.08 7.6
18 Menstruation 0.46 902.0 134
•
1.0 0.14
Mid 0.33 1102 .0 145 1.0 0 .11 -
Menstruation 0.37 1146.0 89. 3.5 0.13 -
Mid 0.37 793.0 158 2.7 0 .01 -
Menstruation 0.28 912.0 135 1.0 0.09 -
Start of
Oral Contraception
(30/ig Etbnyloestradiol
0.15mg D-norgestrel)
Start of
Oral Contraception
(30/"g Ettonyloestradiol
0.15mg D-norgestrel)
